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ABSTRACT
DOWN-REGULATION OF NATURAL KILLER CELL ACTIVATION IN RESPONSE 
TO INFLUENZA VIRUS IN OLDER ADULTS
Yu Jing
Eastern Virginia Medical School and Old Dominion University, 2007 
Director: Dr. Yuping Deng 
Co-director: Dr. Stefan Gravenstein
Immune senescence contributes to influenza-associated high mortality and morbidity 
and reduced vaccine efficacy in elderly people. Type IT  cell (Thl)-mediated immunity 
plays a significant role in Immune responses to influenza infection and vaccination. 
Natural killer (NK) cells secrete significant amount o f IFN-7 , a hallmark Thl cytokine, in 
response to influenza infection. How aging influences human NK cell IFN -7  production 
in response to influenza virus has not been well documented. In this study we employed 
human peripheral blood mononuclear cells (PBMC) and performed intracellular cytokine 
staining and flow cytometry primarily to investigate how aging influences NK cell 
activation with respect to IFN-7  production in response to influenza virus. We have 
found that NK cell IFN-7  production, mediated by both soluble factors and cell-cell 
contact factors is down-regulated in elderly subjects compared to young subjects in 
response to influenza virus. As for soluble factors, IFN-o: and IFN-7  are proven to be 
important in inducing NK cell to produce IFN-7 . The frequencies o f IFN-a-producing 
plasmacytoid dendritic cells (pDC) and IFN-7 -producing T cells in PBMC are lower in 
the elderly subjects than in the young subjects. Further more, pDC from the young 
subjects produce more IFN-o: on a per-cell basis and mediate NK cells to produce more
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
IFN-y than pDC from the elderly subjects. As for cell-cell contact factors, the 
expressions o f NKp44 and NKp46, two natural cytotoxicity receptors on NK cell surface 
specifically recognizing influenza hemagglutinin (HA) expressed on antigen presenting 
cells, are up-regulated upon influenza infection o f PBMC, but display higher expression 
levels in older subjects than young subjects. Our data have demonstrated that aging- 
related numerical and/or functional impairment in pDC and T cells results in lower 
production of IFN-o; and IFN-y, and consequently contributes to the down-regulation of 
IFN-y production in NK cells in response to influenza virus in older adults. How aging 
affects NK cell IFN-y production through influencing cell-cell contact regulation between 
NK cells and antigen presenting cells remains to be elusive. It’s our strong belief that our 
study and the related findings will help enrich our knowledge about how aging affects 
innate as well as adaptive immune system in response to influenza virus, and help build 
the fundamentals for developing more effective prophylactic and therapeutic approaches 
to fulfill the long-term goal o f reducing influenza morbidity and mortality and improving 
the quality o f life for the elderly.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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love and affection throughout my life.
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I. INTRODUCTION
Influenza virus is highly contagious and among those pathogens with greatest potential to 
cause life-threatening epidemic and pandemic outbreaks (1). Influenza-related morbidity 
and mortality increase with age, particularly in people over 65 years old, making 
influenza and its most common complication, pneumonia among the top 5 leading causes 
of death for this age group (2, 3). Vaccination can effectively prevent the occurrence and 
severity o f the disease (2, 4, 5). However, the vaccine efficacy is significantly lower in 
old people than in their young counterparts (3, 4, 6-12). The cause for the age-related 
increase in mortality and morbidity and reduction in vaccine efficacy is related to 
immune senescence (3, 4, 13). Investigations on how the immune responses to influenza 
virus are impaired in older adults will provide the fundamental for developing more 
effective prophylactic and therapeutic approaches for older people. Natural killer (NK) 
cells are the major lymphocytes in innate immune system and play a significant role in 
influenza-induced host defense by eliciting cytotoxicity and secreting IFN-y (14). How 
aging influences NK cell activation, particularly with respect to their function o f IFN-y 
production in response to influenza virus has not been well documented. The overall 
objective o f this study is to investigate the age-related changes and their potential causal 
factors in NK cell activation determined as the frequency o f IFN-y producing NK cells in 
response to influenza virus in older subjects.
1.1 Overview o f Influenza Virus
Influenza viruses are members o f the family o f orthomyxoviridae with single stranded, 
negative sensed segmented RNA genome. Based on antigenic differences in viral nuclear 
protein (NP), influenza viruses are classified into A, B and C three types (15). Influenza 
A and B are the two types known to be associated with diseases in human and animal 
(15).
The journal model for this dissertation is Journal o f  Immunology.
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• Epidemiology o f  influenza in humans
Influenza is a serious public health problem. According to Center for Disease Control, 
each year in the United States, 5% to 20% of the population gets influenza, over 200,000 
people are hospitalized, and about 36,000 people die from influenza (16-19). Influenza is 
associated with high morbidity (over 50%) and mortality in people 65 years and older 
(over 70%). The high morbidity rate is also found in children less than one year old (as 
high as 70%) (1, 20). Majority o f influenza occurs between late fall and early spring, 
indicating influenza is a seasonal disease (2 1 ).
Influenza viruses continuously undergo antigenic variation by two means: antigenic drift 
and shift (1). Antigenic drift involves minor changes in the envelope glycoproteins 
hemagglutinin (HA) and neuraminidase (NA) due to mutation, deletion or other changes 
in genes encoding these proteins during viral replication. Antigenic shift involves major 
changes in these molecules resulted from reassortment o f viral genomic segments when 
more than one strain o f influenza virus co-infect a host cell (1, 22). According to the 
antigenic diversity o f HA and NA, there have been identified 16 HA subtypes and 9 NA 
subtypes o f influenza A viruses (23). Changes in antigenecity o f HA and NA allow 
influenza viruses to evade from host immunity and significantly increases the chance for 
infection (1).
Influenza virus is associated pandemic outbreak (24). Important influenza pandemic 
outbreaks in human history documented since 1889 include those in 1889 (H2N?), 1899 
(H3N8), 1918 (H1N1), 1957 (H2N2), 1968 (H3N2) and 1977 (H1N1) (25). Three 
explanations have been addressed for the formation o f a pandemic strain (1). Antigenic 
shift could facilitate generation o f a new high-virulence strain. Direct transfer o f a high- 
virulence avian strain to human could occur or a human strain that caused an epidemic 
many years ago could re-emerge (1, 26). Direct transfer of a high-virulence strain from 
avian animals to human has been confirmed by the influenza epidemics that took place in 
Hong Kong during 1997-1998 (27). Influenza transmission is through the aerosol route. 
Avian and domestic animals are the important hosts and reservoirs o f influenza viruses
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(1). Close contact with these animals may increase the chance for co-infection as well as 
direct transmission (1, 28).
• Replication o f  influenza virus
Influenza A genome contains 8 negative sensed RNA segments encoding for 10 proteins: 
polymerase B2 (PB2), PB1, polymerase A (PA), hemaglutinin (HA), NP, neuraminidase 
(NA), matrix proteins 1 and 2 (M l and M2), and non-structural proteins 1 and 2 (NS1 
and NS2) (15). The HA residing on the viral envelope mediates attachment o f the virus 
to target cell via binding to sialic acid residues on glycoproteins o f host cell membrane 
(29). After binding, influenza virion enters the cell by endocytosis and arrives in acidic 
endosome, where HA is cleaved and M2 ion channel is activated. Establishment of 
acidic environment in the virion induces alteration in M l/RNP and M l/H A  interactions 
and conformational change in the HA, consequently activating fusion o f viral envelope 
and endosomal membrane (15, 30). The nucleocapsid is released to the cytosol and 
transferred to the nuclear, in which viral replication takes place. Making use o f m7G cap 
from cellular mRNA, the three RNA polymerases PB2, PB1 and PA function in concord 
to transcribe the viral genome into positive sense mRNA and cRNA, the former used for 
protein translation and the latter used as the template for generating new viral genome. 
Newly generated NP protein migrates to nuclear and associates with newly synthesized 
vRNA to form nucleocapsid. The accumulation o f nucleocapsid in cytosol initiates the 
assembly (31, 32). Being facilitated by NA protein, the assembled virions are released 
from the cell via budding process and spread to other cells (31, 33).
• Influenza viral-host interaction
Like many other viruses, influenza virus encodes proteins that interact with cellular 
components and counteract the host anti-viral activity in favor o f its own replication. 
Influenza NS1 protein can modulate viral RNA transcription and replication, and inhibit 
nuclear export o f the host polyadenylated mRNA (34), mRNA splicing (35-37), and 
apoptosis (38). Further more, it is a potent inhibitor for IFN-a production and IFN-a
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Figure 1. Replication o f influenza virus and therapeutic approaches. (Modified, original 
figure from Microbiology @ Leicester: Virology: Orthomyxoviruses or http://www- 
micro.msb.le.ac.uk/3035/Orthomyxoviruses.html)
effector function (39). Particularly, NS1 has been known to be able to bind to dsRNA 
and inhibit dsRNA-induced IFN-o: gene transcription (40, 41). It is also able to interfere 
with 2-5(A) synthetase/RNaseL as well as PKR activation pathways (42-45) to inhibit 
antiviral activity o f IFN-o:. A recent study has shown genes affected by N S1 are not 
restricted to IFN-o:. Those coding for human macrophage inflammatory protein lb  
(MIPlb), interleukin-12 p35 (IL-12 p35), IL-23 p l9 , RANTES, IL-8 , and CCR7 are 
down-regulated by NS1, underlying NS1 may “specifically suppress DC maturation, 
migration, and NK and T-cell stimulatory activity” (46). In addition to NS1, influenza 
HA has been newly revealed to selectively suppress interleukin 12 p35 transcription in 
murine bone marrow-derived dendritic cells (47). IL-12 production is under the 
detectable level in human PBMC stimulated with influenza virus alone (48, 49). Whether 
NS1 and/or HA protein significantly contribute to the cessation o f IL-12 production in 
human PBMC remains unknown.
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• Pathogenesis o f  influenza virus
Influenza virus infects and exclusively replicates in epithelial cells o f the respiratory tract 
and causes most significant pathology in the lower respiratory tract (1). Release o f viral 
particles from the apical surface o f the cells restricts systemic spread o f the virus but 
facilitates accumulation o f virus in the lumen of the respiratory tract for transmission 
through air ways (1). Local inflammation and edema are associated with infected tissues. 
Ciliated epithelial cells can be vacuolated, lose their cilia and become desquamated. Viral 
antigen can be detected in epithelial cells and mononuclear leukocytes. In the case o f 
severe primary viral pneumonia, mononuclear leukocyte infiltration, capillary dilation 
and thrombosis are predominant and viral antigens can be detected in type 1 and type 2  
alveolar cells and macrophages (50). Influenza A and B can cause the same spectrum of 
diseases. Primary viral pneumonia, combined viral-bacterial pneumonia and bacterial 
pneumonia following an influenza infection are three severe conditions associated with 
influenza. Complications are most often in the elderly (1)
• Treatment o f  influenza
Influenza can be treated or prevented by chemical drugs specifically targeting M2 ion 
channel (amantadine and rimantadine), NA protein (Zanamivir and Oseltamivir) or viral 
RNA replication (ribavirin,(51, 52). Distinct from chemical drugs, influenza vaccination 
has been proved to be the most cost-effective method in reduction o f influenza-related 
mortality and morbidity (53, 54). Because o f the antigentic drift, the strains used for 
generating the vaccine have to be determined every year. The vaccine contains three 
influenza strains, one A (H3N2) strain, one A (H1N1) strain, and one B strain, each 
representing one o f the three groups o f viruses circulating among people in a given year 
(1, 55).
There are two types o f licensed vaccines. The first is the inactivated or split trivalent 
influenza vaccine (TIV). It contains killed virus and are effective for both young and 
elderly subjects. The TIV is highly recommended to people at high risk o f influenza, 
including children 6-59 months, people 50 years and older, pregnant women and people
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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with chronic medical conditions (16, 56). Though effective, the TIV efficacy is 
significantly lower in elderly subjects than that in the young, making the elderly people 
less effectively protected by the vaccination (3,12). Immune senescence is believed to 
contribute to the low vaccine efficacy in the older adults (13). The second type of 
influenza vaccine is a live attenuated influenza vaccine (LAIV) or FluMist. FluMist is 
recommended to healthy people between 5-49 years old and has been shown more 
effective to stimulate immune responses in healthy young adults or even high-risk 
subjects, such as children diagnosed with asthma than TIV (16, 57, 58).
1.2 Significance of Influenza Virus in Aging
Influenza/pneumonia is the fifth leading cause o f death for people 65 years and older (59) 
As recorded for the United States in year 2000, influenza/pneumonia claimed 60,261 
lives aged 65 years and older, which constituted 0.173% of the total population and 3.3% 
o f elderly o f the same age range in the country (59). Influenza infection is associated 
with high mortality and morbidity rates in the elderly. However, the vaccine efficacy is 
significantly lower in older people than that in the young. The lower vaccine efficacy is 
manifested by age-associated decline in intact humoral response to influenza vaccination 
and low protective rate o f the vaccines. In particular, seroconversion, measured as fold 
o f increments in sera antibody titer upon vaccination, and seroprotection, measured as 
certain dilution factor o f the sera antibody, rates are significantly lower in older subjects 
than those in the young (8 , 60). More over, in contrast to 70-90% protective rate in 
young adults, there is only 30-40% of influenza infection that can be prevented by 
vaccination in the elderly (3, 8-11). With the unprecedented enlargement o f the body of 
aged population, it is believed influenza will have a significant impact on the quality of 
life for the elderly.
1.3 Overview o f Aging
Aging is defined as “a process that converts healthy adults into frail ones with diminished 
reserves in most physiologic systems and an exponentially increasing vulnerability to
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most diseases and to death” (59). Aging has been viewed as a distinct variable from 
diseases. Richard Miller has proposed that slowing-down of aging alone will produce 
longer life expectation than curing any individual or combinations o f the diseases that are 
leading causes o f death for the elderly (Figure 2) (59, 61). According to R. Miller, a 
question yet to be answered is “which age-related changes can be considered a part of 
normal aging”. A study to examine aging effect on a particular event by comparing 
healthy young and “healthy” elderly subjects most time has to be in compliance with the 
fact that elderly are rarely completely “disease-free” and any disease could be a potential 
“confounding” factor for normal aging (59). On the other hand, if  the elderly subjects 
whose health status is strictly comparable to that o f their younger counterparts are used in 
a study, how much these extremely healthy subjects would represent the typical elderly 
population will be questionable.
just Like Today— average 50-year-old woman lives to 81
Cure Cancer Today 
Cure Heart Disease Today
Cure Cancer and H eart Disease Today
Cure Cancer, Heart Disease, Stroke, and Diabetes Today 
Slow Down Aging
40 50 60  70
Years of Life Left at Age 50
80
Figure 2. Life expectancy at age o f 50 by disease categories. (Source: R.A. Miller/ 
University o f Michigan)
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• Epidemiology o f  aging
Aging o f human population has formed a global trend. The growing elderly population is 
not only caused by “general increase in the overall population size” but also more 
influenced by increased longevity o f older people accompanied by declining birth rate 
following the birth boom in 1940’s and 1950’s (59). According to US Census Bureau, 
actual or projected total US population are 76.1 million in 1900, 152.3 million in 1950,
276.1 million in 2000 and 403.7 million in 2050, with 4.1%, 8.2%, 12.6% and 20.3% in 
each of these years accordingly being people 65 years and older. In 1900, only 39% male 
and 43% female could live till 65 years with average life expectancy o f 32-49 years. By 
1997, the percentages have been increased to 77% for male and 86  % for female with 
average life expectancy o f 67-80 years (59).
Aging is associated with greater mortality and morbidity. A wide range o f diseases such 
as cancer, cardiovascular and neurodegenerative disorders have a significant age- 
dependent onset (62). In 2000, heart diseases and cancer has claimed nearly one million 
older lives in the United States, which accounts for over 50% o f total death in older 
people in the year. For over two decades, heart diseases, sequentially followed by cancer, 
stroke, chronic obstructive pulmonary diseases (COPD), pneumonia/influenza, diabetes 
mellitus and Alzheimer’s diseases have been the leading causes o f death for people over 
65 years o f age (59). With the rapid increase in the aging population, it is important for 
us to gain better understanding about the aging mechanisms. This provides the 
fundamentals for developing more effective prophylactic and therapeutic approaches for 
diseases associated with advanced aging.
• Biology o f  aging
Aging, although not a disease, like many diseases is a genetically controlled, 
environmentally influenced process. Studies on caloric restriction (CR) or a single gene 
mutation that help produce long-lived animals in yeasts, nematodes, fruit flies and 
rodents have evidenced close relationships between activation o f dafl 6 gene, lower level
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of insulin and insulin-like growth factor 1 (IGF-1), increased DNA repairing ability and 
postponement o f aging (59, 63, 64). Caloric restricted mice and Ames dwarf (AD) mice, 
the latter carrying a mutation at Propl gene on chromosome 11 leading to their growth 
retardation live 30-50% longer and share lower body temperature and lower level o f IGF- 
1 than the control mice (59, 63). Single gene mutation in certain d a f  or age genes that 
has produced longevity in fruit fly Drosophila melanogaster and soil nematode 
Caenorhabditis elegans is found to be associated with activation o f dafl 6 gene whose 
regulatory factor da£2 is homologous to insulin and IGF-1 receptors in mammals (65, 6 6 ). 
Long-lived yeasts and worms have shown stronger resistance to cellular damage caused 
by ultraviolet, oxidizing agents and overheating and IGF-1 has been reported to play a 
significant role in mediating DNA repair (59, 67). These evidences suggest the aging 
process may be fundamentally related to cellular repair system.
1.4 Immunology o f Aging
Aging o f the immune system or immune senescence, leads to immune dysfunction. 
Immune senescence has been proposed by Walford to account for three major causes o f 
disease in old age: increased autoimmunity, higher occurrence o f cancer and increased 
susceptibility to infectious diseases (6 , 6 8 ). Changes in both innate and adaptive 
immune systems are found with aging.
• Innate immune system in aging
In the innate immune system, TLRs are a family o f pattern recognition receptors binding 
to pathogen-associated molecular patterns (PAMPs) and serve as a sentinel to induce 
cytokine production (69, 70). TLRs are widely and differentially expressed in antigen 
presenting cells as well as lymphocytes in human PBMC. Human and mouse studies 
have indicated myeloid DC (mDC) and monocytes express TLR 1, 2, 4, 5, 6  and 10 either 
at mRNA level or at protein level and mainly respond to bacterial stimuli by producing 
TNF-alpha, IL-6  and IL-12. Plasmacytoid DC (pDC) preferentially express TLR7 and 9 
proteins, which confers their ability to respond to viruses and CpG by producing large
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amount o f type I IFNs (71, 72). TNF-a, IL-12 and IFN-a are able to stimulate Thl cell- 
mediated immune response while IL-6  is able to stimulate B cell development and 
differentiation into plasma cells to produce antibody (73, 74). Characteristics of 
mammalian TLRs are summarized in Table I. Renshaw and colleagues reported the 
expression o f TLR 1-9 in APC of aged mice is down-regulated compared with young 
mice. Consistently, declined TLR expressions contribute to less production o f cytokines 
TNF-alpha and IL-6  in macrophages stimulated by TLR ligands (75), suggesting TLR 
pathway is affected by aging process. Among cytokines and their producing cells, type I 
IFNs and pDC have been drawn special attention and being investigated prosperously in 
recent years (76-78). However, studies on their age-related changes are far from 
sufficient even after pDC was identified as the most potent type IIF N  producing cells 
(79-81).
In the innate immune system, NK cells are the major type o f cells derived from lymphoid 
lineage and represent 5-15% of total human PBMC (82-84). Two distinct subtypes of 
NK cells can be identified based on their differential expressions o f cell surface antigen 
CD56, and CD 16. CD56brightCD16dim NK cells preferentially secrete high levels o f IFN-y 
and CD56bnghtCD16dim NK cells primarily execute cytotoxicity and secrete relatively 
lower levels o f IFN-y upon activation (84, 85). It is known in human peripheral blood 
NK cell frequency increases and their per-cell-based cytotoxic activity declines with age 
(86-90). Details o f phenotypic and functional properties o f NK cells will be discussed in 
session 1.6 .
• Antigen presentation in aging
Dendritic cells, monocytes are the professional antigen presenting cells (APC) that link 
the innate and adaptive immune systems. Dendritic cells, existing in peripheral blood at a 
frequency of less than 1%, include two major subsets, myeloid dendritic cells (mDC) and 
plasmacytoid dendritic cells (pDC) (94). Resting human mDC expresses high level o f 
CD 11c, an unconventional MHC class I-like molecule and low level o f CD 123, IL-3 
receptor alpha chain. On the opposite, resting human pDC expresses high level o f
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Table I. Characteristics o f mammalian Toll-like receptors (69, 72, 91-93)









































diacyl lipoprotein no macrophage, 
monocytes, 
mDC, T
7 homodimer cytoplasm ssRNA no pDC, NK
8 homodimer cytoplasm ssRNA no NK, TREG
9 homodimer cytoplasm non-methylated
CpG
no pDC, B, T
10 unknown unknown unknown no macrophage, 
epithelial cell
11 unknown unknown uropathogenic 
bacteria, profilin- 
like protein in 
protozoa
yes mDC
CD123 but no CD1 lc  (95, 96). Monocytes comprise about 5-10% o f total human PBMC 
and express cell surface marker CD 14, a co-receptor along with Toll-like receptor (TLR) 
4 for bacterial lipopolysacchrides (97). Antigen presentation involves formation of 
complex o f endogenous or exogenous antigens to be presented with MHC class I or class 
II molecules. The majority o f protein-derived antigens are short (8-11 amino acids) 
peptides (98). Some of these peptides are derived from newly generated proteins, 
forming complexes with MHC class I molecules and presented to CD8+ T cells. Others
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are derived from exogenous proteins, forming complexes with MHC class II molecules 
and presented to CD4+ T cells or forming complexes with MHC class I molecules and 
cross primed to CD8+ T cells (98-101). In addition to peptides, new forms o f protein- 
originated antigens have been recently identified. These include the intact proteins and 
the complexes formed by peptides and heat shock proteins, both being found to be 
involved in MHC class II-restricted presentation and/or MHC class I-related cross­
priming (99,102-105). Evidence has been shown that aged mice alveolar macrophages 
are less efficient in antigen presentation than young cells, indicating antigen presentation 
is potentially affected by aging (106,107).
• Adaptive immune system in aging
Beyond the innate immune system, the adaptive immune system, in which T and B 
lymphocytes are major cell types, is characterized with specificity, memory and tolerance 
in eliciting immune responses. Although age-associated changes in the number o f total 
peripheral T lymphocytes have not been convinced, numerous functional impairments in 
T cells have been displayed with advanced aging. First, loss o f CD28 in aged T cells 
significantly reduce T cell proliferative ability though expression of the early activation 
signals, such as CD69, is well preserved (108-111). Second, aged T cells are known to be 
deficient o f calcium (112). Calcium is critical for many cellular events. Calcium 
deficiency can lead to failure o f activation of important enzymes, such as MAPK and 
MEK involved in signal transduction pathways and consequently affect cytokine 
production, cell proliferation, and cytotoxicity (113-116). Third, aging influences T cell 
transcriptional factors directly. NF-kB and AP-1 have been found to be inactivated in 
aged T cells (117). IL-2 is critical for T cell proliferation and able to stimulate NK cell 
differentiation and activation (81, 118). Down-regulation of IL-2 expression is largely 
accounted for by the impairment o f transcriptional factors in aged T cells (119).
T cells are highly heterogeneous and aging influences the frequency and function of 
different T cell subtypes. Type 1 (Thl) and type 2 (Th2) T helper cells are the two major 
subtypes o f CD4+ T cells, the former stimulating cell-mediated immunity and producing
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IFN-7 , IL-2 , and the latter stimulating humoral immunity and producing IL-4, IL-5 and 
IL-10 (98). Productions o f Thl cytokines and Th2 cytokines often counteract each other 
(98). There appears to be a shift in predominance o f helper T cell responses from type 1 
to type 2 with advanced aging (81, 120, 121). Diversity in clonal expansion is a critical 
feature o f T cell activation. However, restricted TCR repertoire has been found to be 
associated with CD8+ T cells (122-124). T cells can also be classified into naive versus 
memory T cells. It is known the frequencies o f both CD4+ and CD8+ naive T cells in 
human peripheral blood decrease with age (125). Diminishing o f the naive cells is due to 
thymic involution (125), which contribute to increased susceptibility to new pathogens in 
older subjects. Accumulated memory T cells may impair the long term T cell activation 
(79,126, 127). Naive/memory T cell ratio declines with age with CD8+ more rapidly 
than CD4+ T cells (128-130). Interestingly, the frequencies o f different subtypes o f T 
cells do not change with age consistently at least for CD8+ T cells. Gupta and Hong have 
reported in human peripheral blood the frequencies o f naive (CD45RA+CCR7+) and/or 
central memory T (TCM, CD45RO+CCR7+) CD8+ cells are decreased with age, 
whereas those o f effector memory cells (TEM, CD45RO+CCR7-) and effector (TEMRA, 
CD45RA+CCR7-) CD8+ T cells are increased with age (128, 131). Besides 
conventional T cells, T regulatory (TREG) cells are also influenced by aging. TREGs 
express Foxp3 transcriptional repressor and play an immuno-suppressive role in 
maintaining immunological tolerance and homeostasis (132). It has been found TREG 
number in human peripheral blood increases with age, which may lead to the imbalance 
o f TREG homeostasis and predispose the aged individuals to higher risk o f autoimmune 
diseases (133-135).
In humoral immune system, age-associated changes are indicated to be associated with B 
cells in multiple aspects. With respect to proliferative responsiveness to signals, reduced 
RNA synthesis and DNA replication upon stimulation with immunoglobulin (slg), 
polyclonal activator staphylococcus aureus Cowan I (SAC), CD20 or CD40 have been 
detected in aged human B cells (136). With respect to B cell genesis, studies have shown 
increased longevity is associated with decreased number of de novo B cells (137, 138) 
but no change has been observed in the number o f peripheral blood B cells in mouse and
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human (120,139). Further more, Studies in human and mice also show aged mature B 
cells exhibit altered B cell receptor (BCR) repertoire, particularly in V region (140). 
Antibody production in majority o f B cells requires the assistance o f CD4+ T cells. T 
cells interact with B cells and induce hypermutation in immunoglobulin genes in B cells. 
The age-related dysfunction o f T cells in conjunction with the intrinsic impairment o f B 
cells significantly affects the production o f antibodies in the elderly(141, 142). This is 
reflected by more restricted antibody repertoire in the elderly than that in young people. 
The malfunction o f humoral immune system results in the impaired primary and 
secondary humoral responses to vaccination in older people (143, 144). For instance, the 
peak titer o f antibody in older subjects tends to be lower and occurs later than in younger 
subjects (1 2 0 ).
1.5 Overview o f Immune Responses to Influenza Virus
Influenza virus induces humoral as well as cell-mediated immune responses. Humoral 
immunity plays a crucial role by providing protective antibodies to neutralize infectious 
virion. Specific antibodies to HA, NA, NP, M l and M2 have been detected in human or 
mouse in response to influenza infection but only HA and NA antibodies (IgM, IgG and 
IgA) have been proven to possess primary protective function (1,145). Influenza- 
induced antibody can not provide life long protection against the disease. Possible 
reasons include a diminution o f protective antibody with time and the rapid emergence of 
new viruses with unprecedented antigenic epitopes in HA (1, 146). CD4+ type 2 T (Th2) 
cells mediate antibody production via physical contact with B cells and cytokine 
secretion to stimulate B cell development and influence Ig subclass switching. IL-4, IL- 
5, IL-6  and IL-10 are Th2 cytokines detected in response to influenza stimulation (147, 
148). IL-4 has been found to stimulate the production o f IgGl and IgE in mice (149).
Cell mediated immune responses (CMI) to influenza virus involve cytotoxicity and Thl 
cytokine production (150). Cytotoxicity is elicited by T cells and NK cells. MHC class 
I-restricted CD8+ cytotoxic T cells have been found to recognize influenza HA, M, NP 
and PB2-derived antigens (151, 152). Recent data indicate that T cell cytotoxicity is not 
restricted to CD8+ T cells but extends to CD4+ T cells. MHC class Il-restricted porferin-
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mediated cytotoxicity by CD4+ T cells have been identified towards influenza vims and 
other vimses (153, 154). NK cell-mediated cytotoxicity involves a variety o f NK cell 
surface receptors and will be discussed in session 1.7. Type IT  helper (Thl) cells play an 
important role in mediating the responses to influenza infection and vaccination through 
secreting cytokines such as IL-2 and IFN-y (7,150). In addition to T cells, NK cells 
secrete large amount o f IFN-y in response to influenza stimulation (155, 156). Thl cell 
and NK cell functions have been shown to be significantly modulated by antigen 
presenting cells and/or their secreted cytokines (157-160), which will be addressed in 
detail in session 1.6. Upstream to cytokine production, TLRs have been proven to 
significantly contribute to immune activation in response to influenza vims. Toll-like 
receptors (TLR) serve as the important sentinels for pathogen in the innate system and 
largely mediate Thl immunity (161). Influenza vims contains a single stranded RNA 
genome and produces dsRNA intermediate during its replication, thus is able to activate 
TLR3, 7 and 8 constitutively expressed or induced in NK cells, pDC and/or monocytes 
(162-164). Some activation may require an additional factor, such as IFN-y to facilitate
(165).
1.6 Significance o f Thl Immunity Induced by Influenza Stimulation in Aging
Influenza infection and vaccination induce humoral and cell-mediated immune responses 
(CMI). CMI is believed to play an important role in conjunction with antibody response 
for complete clearance o f influenza infection and largely determines the vaccine efficacy
(166). Age-associated impairment in CMI has been suggested to account for the 
increased susceptibility to influenza in the elderly (150). Immune modulation via Thl 
and pro-Thl cytokines is one important aspect o f influenza vims-induced CMI because 
these cytokines function to stimulate T cell proliferation, display effector anti-viral 
activity, modulate other cell function and influence antibody subclass profile (167). IL-2 
and IFN-y are two well defined Thl cytokines. IL-2 is secreted by activated T cells and 
has been shown to be indispensable in stimulating both Thl and cytotoxic T cell 
proliferation, differentiation, and activating NK cells (168, 169). In addition, IL-2 
enhances B-T cell interaction so as to contribute to antibody generation (170). IL-2
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production has been shown to be down-regulated or remain at a comparable level in older 
subjects compared to young control in response to influenza infection and vaccination, 
depending on specific experimental conditions, indicating influenza-related down- 
regulation o f Thl immunity with aging is not solely attributed to the age-related changes 
in IL-2 production (171-175). IFN-7 is a hallmark Thl cytokine and secreted by 
activated T cells and NK cells upon influenza stimulation. Besides an effector cytokine 
delivering direct anti-viral effect to viral infected cells, IFN-y is a critical immune 
modulator and influences other immune cell function and antibody subclass profiling 
(176). For instance, IFN-y has been known as the primary macrophage-activating factor 
that up-regulates MHC class I and II molecules to stimulate antigen presentation and 
influence expression of other cytokines, chemokines to favor cellular antiviral 
activities(176-178). In addition, it is able to up-regulate TLRs in macrophage and 
epithelial cells (179). As a Thl cytokine, IFN-y stimulates Ig class switching in favor o f 
IgG2a and IgG3 in mouse (180,181) and IgGl in human (182,183) in vitro and/or in 
vivo (184). In human, systemic levels o f IgGl and IgG3 are important for complement 
fixation and Ab-dependent cellular cytotoxicity (185). IgG is the dominant Ig subclass 
stimulated by trivalent influenza vaccine and IgGl is the most prominent IgG isotype 
(182, 186). IFN-y production has been shown to be down-regulated in older subjects in 
response to influenza infection and vaccination (173, 187). Our recent data has indicated 
that Thl response determined as the frequency o f IFN-y secreting CD4+ Thl and 
cytotoxic influenza-specific memory T cells (ISMT) declines with age and correlates 
with antibody response to influenza vaccination(174, 188). Consistent with our finding, a 
new observation has indicated Thl but not antibody response correlated with the outcome 
o f influenza vaccination (189). These evidences have suggested CMI, particularly Thl 
immunity, contributes to reducing the morbidity and mortality o f influenza in the elderly 
and capable o f influencing vaccine effectiveness.
The production o f IFN-y can he modulated by pro-Thl cytokines secreted by antigen 
presenting cells. For instance, IFN-o/jS alone or synergistically with IL-18 is able to 
induce type IT  cell and NK cell activations (190). One prominent role o f IL-18 is to act 
together with IFN-o//3, IL-12 and/or IL-23 to activate Thl and NK cells to induce IFN-y
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production and NK cytotoxicity (157,191-193). Although IL-12 and IL-23 are not 
induced in human PBMC stimulated with influenza virus, IFN-O! /j3 is abundantly 
produced by pDC and monocytes in response to influenza infection (48, 49, 194, 195). In 
general, pDC is the predominant cell type in production o f type I IFNs responsive to viral 
infection or CpG via TLR-7 or TLR9 pathway (196, 197). However, the accurate 
comparison in the amount o f type IIF N  production responsive to influenza infection 
between pDC and monocytes has not been documented. In addition to direct antiviral 
effect and induction of IFN-y in T cells and NK cells, type I IFN and pDC has been 
recently shown to mediate antibody production (198, 199). Although Type I IFNs and 
pDC are demonstrated to play a significant role in antiviral immunity, how important 
they are in influenza-induced immunity and how relevant they are to age-associated 
decline in IFN-y production in response to influenza stimulation in human remains to be 
investigated.
1.7 Significance o f NK Cell Activation Induced by Influenza Stimulation
As we described earlier in session 1.6, Thl immunity is important in response to influenza 
stimulation and Thl response determined as the frequency of IFN-y secreting CD4+ T 
cells is declined in elderly subjects. NK cells secrete IFN-y in response to influenza 
stimulation therefore participate in influenza-induced Thl immunity. However, how 
IFN-y production in NK cells is maintained in older people in response to influenza 
infection remains unknown. Our study will be focused on investigating the activation, 
specifically the IFN-y production in human peripheral NK cells in response to influenza 
virus and attempts to unravel the important regulatory factors that contribute to the age- 
associated changes in NK cell activation in response to influenza virus.
• Overview o f  NK cells
NK cells are the major lymphocytes in the innate immune system. Capable o f eliciting 
cytotoxicity to virus-infected or tumor cells via MHC class I molecule-dependent or 
independent mechanisms, NK cells play a crucial role in controlling viral load at early
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stages o f infection and performing immune surveillance on tumorigenesis (82, 200). NK 
cell function is mediated by a spectrum of cell surface receptors (201, 202). NK surface 
receptors can be classified into two categories, activating receptors and inhibitory 
receptors. Activating receptors include natural cytotoxicity receptors (NCRs, NKp30, 
NKp44 and NKp46), NKG2 family o f receptors (NKG2 A/B, C, D, E and F), CD 16, 
CD244, CD161, and CD226 (DNAM-1) and CD96. NCRs recognize viral or tumor 
molecules and trigger lysis in abnormal cells (200). NKG2 receptors form homodimers 
or heterodimers with CD94 and generate either activating (NKG2C or D) or inhibitory 
(NKG2A) effect through binding to MHC I chain-related proteins (203, 204). CD16 
mediates direct and/or antibody-dependent cell-mediated cytotoxicity (ADCC) (205). 
CD244 displays MHC class I-independent activating or inhibitory effects depending upon 
stimuli (206). CD161 recognizes non-peptide antigens and is found to be co-expressed 
with T cell receptors (TCR) on natural killer T (NKT) cells (207). CD226 and CD96 
have been shown to recognize poliovirus receptor (PVR) and suggested to mediate 
cytotoxicity and cell adhesion (208). NK cytotoxicity can be prevented by NK 
inhibitory receptors Ly49, KIR and NKG2A/CD94 in a MHC-I-dependent manner (209, 
210). NK cells express TLR 3 which enable them to recognize dsRNA and TLR7/8, 
which enable them to recognize ssRNA (211,212). Activated NK cells produce IFN-y, 
display cytotoxicity and mediate immune regulation. In addition to IFN-y, NK cells 
secrete GM-CSF, which is known to be capable to induce monocyte differentiation into 
mDC or macrophages in the presence or absence o f IL-4, respectively in vitro (213, 214).
• N K  cell activation in response to influenza virus
NK cell activation involves cytotoxicity, IFN-y production and cell proliferation and is 
regulated by cell-cell contact factors and soluble cytokines, the latter through STAT- 
participated signal transduction pathways with ST ATI mediating cytotoxicity and 
STAT4 inducing IFN-y production (215, 216).
NK receptors mediate cytotoxicity via MHC class I-dependent or independent 
mechanism. In an MHC class I-independent manner, intact influenza viral protein HA
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cross-presented or attached to the surface o f infected cells, has been found to be 
recognized by natural cytotoxicity receptors NKp44 and NKp46 via HA binding to the 
sialic acid residue attached to galactose on the NCR receptors, supporting a significant 
role of receptor-mediated cell-cell contact regulation in the NK cell activity specifically 
in response to influenza stimulation (217-219).
NK cells comprise 2 major differentiation subsets differed by surface expressions o f 
CD56 and CD16 (84). CD56dimCD16bnght NK cells preferentially execute cytotoxicity 
and CD56dimCD16bnsht NK cells secrete IFN-y (84). In spite o f functional polarity 
displayed by subsets o f NK cells, IFN-y production has been shown to correlate with the 
lytic function in human peripheral NK cells (220), suggesting concordance in activity 
between the two NK subsets. As we described earlier, NK cell IFN-y production can be 
modulated by type I interferons via STAT4 signal transduction pathways (216). In fact, 
NK cells not only produce IFN-y but are influenced by IFN-y for their activation. Human 
peripheral NK cells exist in mature or immature status with mature cells being the 
majority and able to produce IFN-y. IL13+ immature NK cells have been shown to be 
able to differentiate into IL-13- cells in the presence o f IL-2 and further mature into IFN- 
y producing cells by IFN-y (221). He and colleagues has postulated “T-cell dependent 
production o f IFN-y by NK cells in response to influenza A virus” in a IL-2 dependent 
manner, supporting the role o f IFN-y in NK cell differentiation and activation (222).
Thus, both type I interferons and IFN-y are playing a significant role in activating NK 
cells in response to influenza infection. Unfortunately, the importance o f these soluble 
factors in influenza-related immunity in an aging context remains unclear.
NK cell response to influenza stimulation is not restricted to infection but extends to 
vaccination. Skoner and Mysliwska and colleagues have reported NK cytotoxicity can be 
augmented during the acute phase and convalescent phase post vaccination with either 
inactivated or live vaccine (155, 156). In addition, higher NK activity post vaccination 
have been shown to correlate with higher HA antibody titer and better protection against 
clinical infection (155, 156, 223). These evidences indicate NK cells may not only be
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important in defending against acute infection but also participate in preventing influenza 
post vaccination.
NK cell frequency in peripheral blood increases with age but cytotoxic activity decreases 
in the elderly in response to influenza infection and vaccination (87-90). IFN-y 
production is one o f the most important activities o f NK cells. How aging influences NK 
cell activation, particularly IFN-y production has far less been documented. In this study, 
we have compared the frequency o f IFN-y producing NK cells in PBMC in response to 
influenza infection between young and older subjects and investigated how aging 
influences the regulatory components o f NK activation and consequently contribute to 
the reduced IFN-y production in NK cells in response to influenza virus in the elderly.
1.8 Hypothesis and Specific Aims
As described earlier NK cell activation manifested by IFN-y production *n response to 
influenza virus is regulated via soluble factors and cell-cell contact mechanism. 
Specifically, pro-Thl/Thl cytokines IFN-O! and IFN-y along with NK cytotoxic receptors 
(NCRs) and/or viral protein HA involved in cell-cell recognition between NK cells and 
antigen presenting cells may play an important role in regulating NK cell activation.
How aging influences the regulatory factors for NK activity and leads to altered IFN-y 
production in NK cells in the elderly in response to influenza virus have been the focus of 
this study. Components potentially contributing to NK cell IFN-y production in response 
to influenza virus involved in current study are depicted in Figure 3.
• Hypothesis
We hypothesize the impairment in soluble factors, such as the pro-Thl/Thl cytokines 
secreted from pDC and T cells, and/or the defect in expression of cell surface proteins 
involved in cell-cell contact between NK cells and monocytes contributes to the down- 
regulated NK cell activation in response to influenza virus in older subjects.
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Figure 3. NK cell IFN- 7 production and cytotoxicity in response to influenza virus is 
regulated by proThl/Thl cytokines as well as cell-cell contact
Influenza virus infects human PBMC and triggers IFN- a  production in monocytes and 
dendritic cells (pDC and mDC). IFN-a in conjunction with other cytokines, such as IL- 
18, induces NK cell to generate IFN-7 . At the same time, NK cytotoxicity and IFN-7  
production can be induced by physical contact o f NK cells with viral infected 
monocytes via NK receptor-MHC I or viral HA protein recognition. Further more, 
IFN- 7  secreted from T cells may activate monocytes and indirectly augment NK cell 
activities. Grey circles represent IFN-a or IFN-7  and white circles represent other 
soluble factors.
• Specific aims
To test this hypothesis, the following two specific aims have been addressed:
1. To examine to what extent the impairment in soluble factors, particularly the pro-Thl 
cytokines secreted by pDC and T cells play a role in the reduced IFN- 7  production in NK 
cells in response to influenza virus in older subjects.
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2. To examine to what extent the reduced IFN-y secretion by NK cells in older subjects is 
due to changes in the expression o f cell surface receptors/proteins involved in cell-cell 
contact regulation in NK cell activation in response to influenza virus.
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II. MATERIALS AND METHODS
II. 1 Experimental Design
The following schematic graph (Figure 4) describes the experimental design o f this study. 
The study was focused on investigating the factors regulating and contributing to the 
down-regulation o f NK cell activation, specifically IFN -7  production in NK cells in older 
subjects compared to young subjects in response to influenza virus. To achieve Specific 
A im l, we propose to confirm the roles o f IFN-a and IFN-y in regulating NK cell 
activation in response to influenza virus followed by investigating how aging influences 
cytokine-producing cells pDC and T cells and consequently influences NK cell IFN-g 
production. To achieve Specific Aim 2, we propose to confirm the roles o f cell-cell 
contact between NK cells and antigen presenting cells in regulating NK cell activation in 
response to influenza virus followed by examining how aging influences components 
involved in the cell-cell contact regulation.
II.2 Human Subjects and Cells
• Human subjects and peripheral blood mononuclear cells (PBMC)
Healthy young (21-45 years old) and healthy older (60 years and older) volunteers were 
recruited to this study upon proper consenting. All documents related to recruiting 
human subjects for this study were approved by Institutional Board Review (IRB) at 
Eastern Virginia Medical School. PBMC were processed at room temperature (RT) from 
heparinized whole blood. Briefly, the whole blood was centrifuged at 320 g for 10 min. 
Buffy coat (PBMC) were aspirated and laid onto a Ficoll reagent, histopaque 1077 
(Sigma-Aldrich, St. Louis, MO) followed by centrifugation at 650 g for 30 min. After 
Ficolling, PBMC were washed twice with RPMI media (Invitrogen, Carlsbad. CA) by 
centrifugation at 500 g and 320 g sequentially for 10 min each time, counted by 
automatic counter machine (Coulter Ac • T, Beckman Coulter, Miami, FL) and re­
suspended in CTL media (RPMI1640 media containing 10% FBS, 2 mM of L-Glutamine,
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100 U o f penicillin, 100 /tg/ml o f streptomycin and 55 nM of 2-mercaptoethanol) at a 
concentration o f 1 million PBMC per ml for downstream experiments.
HYPOTHESIS:
Defects in soluble factors and/or cell-cell contact regulation contribute to NK cell activation down- 
regulation in response to influenza viurs in older people
SPECIFIC AIM 1:
Role of soluble factors, particularly pro- 
Thl/Thl cytokines IFN-a and IFN-g
SPECIFIC A IM 2:
Role of molecules involved in cell-cell contact regulation, 
particularly NKp44, NKp46 and influenza HA
OBSERVATION:
One aspect of NK cell activation (IFN-g secretion) in response to influenza virus is down-regulated in
older subjects.
EXPERIMENTS:
1) Examine the correlations between NK cell 
activation, amount of IFN-a in PBMC and T cell 
activation in response to influenza virus.
2) Examine the effects o f IFN-a and IFN-g on 
NK cell activation in response to influenza virus.
3) Examine the effects o f pDC and T cells on 
NK cell activation in response to influenza virus.
4) Examine the frequency of and functional 
changes inpDC and/or T cells andpDC- 
mediated NK cell activation in response to 
influenza vims in older people as compared to 
young adults.
EXPERIMENTS:
1) Examine to how NK cell activation in response to 
influenza vims relies on soluble factors versus cell-cell 
contact regulation.
2) Compare the expression of NK cell receptors 
NKp44 and NKp46 between young and older subjects.
3) Compare the expression of influenza HA on 
influenza-stimulated monocytes between young and 
older subjects.
4) Examine the frequency of monocytes in PBMC and 
monocyte-mediated NK cell activation in response to 
in fluenza v im s in older people as compared to young 
adults.
Figure 4. Experimental design o f the current study
II. 3 Influenza Virus
• Propagation o f  influenza virus
The influenza virus used in this study was A/Sydney/05/97 (H3N2, Bio-safety level II, 
seed virus from Center for Disease Control, Atlanta, GA). The A(H3N2) subtype 
emerged in 1968 and is present in influenza trivalent vaccine (TIV) (16, 224). The virus
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was propagated in embryonic chicken eggs by our lab staff. Briefly, fertilized chicken 
eggs (CBT Farms, Chester Town, MA) were incubated at 37°C for 10 days. The viability 
o f the embryos was checked with candle in dark. At room temperature, 0.1 ml o f 1:1000- 
diluted seed virus in diluent buffer ( lx  PBS, pH 7.2 containing lOOU/ml penicillin, 
1 0 0 jag/ml streptomysin and 50/xg/ml gentamycin) was injected to the egg from ethanol 
(70%)-sprayed top o f the egg with 1-ml tuberculin syringe attached to a 2 2  gauge-one- 
inch needle under sterile conditions. Injection site was sealed with glue and the eggs 
were incubated at 37°C for 48 more hours before being harvested. For harvesting 
allantoid fluid, ethanol-sprayed top o f eggs was broken and allantoid fluid was collected 
with a sterile pipette. Allantoic fluid containing A/Sydney virus was filtered via 0.4 um- 
pore size nitrocellulose membrane and was aliquoted into working size and stored at the - 
80°C until use. The aliquots were used only once to minimize freeze-thaw cycle. All 
procedures were conducted under the Guidelines for Bio-safety as detailed in the 
Biosafety in Microbiological and Biomedical Laboratories (BMBL) published by the 
CDC and by the Office o f Safety at the Eastern Virginia Medical School.
• Titration o f  influenza virus
The viral stock contained 107 tissue culture infectious dose 50 (TCID50)/ml o f live viruses 
as tested in Madin-Darby canine kidney (MDCK) cells and 1024 hemagglutinin unit 
(HAU)/50ul as tested with chicken red blood cells. For procedures to determine TCID50, 
please refer to Karber’s method described in the reference(225). To determine HAU, 
fifty microliter o f 1:20 diluted viral stock in PBS (pH 7.4, GIBCO/Invitrogen, Carlsbad, 
CA) was placed in the first column of V-bottom 96-well plate (in duplicates and serially 
diluted at 1 :2 ratio for the remaining columns with each well in the columns containing 
50 /xl o f the diluted virus. Fifty microliter o f 0.5% chicken red blood cells (CRBCs) was 
added to each well and the plate was incubated at room temperature for 45 min. 
Agglutination was evaluated and using the criteria described earlier(l 1). HAU was 
calculated according to the formula HAU/50 jil =10x2", where n is the highest column 
number in the plate where agglutination occurs.
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II.4 Assays and Specific Methods
• Live cell staining, intracellular cytokine staining and flow  cytometry
For cell surface antigen only staining, 1 million or less live cells were co-stained with 
fluorescent-conjugated antibodies against cell surface antigens in 1% BSA-PBS at a 
volume o f 26 fil per well in 96-well U-bottom tissue culture (TC) plate at RT for 20 min 
followed by 2 times o f washing with 1%BSA-PBS. The cells were then re-suspended in 
200 pd o f 1%BSA-PBS, placed on ice and ready for flow cytometry analysis 
(FACSCalibur, BD Biosciences, San Diego, CA). For analysis, forward scanner (FSC) 
and side scanner (SSC) were used to gate PBMC or specific cell types together with 
specific antigens. A total 20,000 to 200,000 events per sample, depending on the relative 
proportion o f cells o f interest were saved for analysis (CellQuest 3.3 software, BD 
Biosciences, San Diego, CA). For intracellular cytokine staining, cells were fixed with 
1% paraformaldehyde-PBS, permeablized with permeablization buffer (Becton 
Dickinson, San Diego, CA) followed by one time washing with 150 ju.1 o f 1%BSA-PBS. 
Then the cells were treated the same way as for live cell staining.
• Detection o f  cell activation by Fastlmmune (FI) assay
Fasthnmune assay consists o f 2 consecutive procedures, culture set-up followed by 
intracellular cytokine staining and flow cytometry. To set up cultures, one million 
PBMC, pDC-, T cell- or NK cell-deducted PBMC, or different amount (see 
corresponding figure description in result session) o f selectively isolated cells were 
stimulated with or without 1 pd (104 TCID50) o f influenza virus A/Sydney in 150 pd of 
cytotoxic T lymphocytes (CTL) media in 96-well U-bottom TC plate at 37°C overnight. 
Brefeldin A, a reagent that interferes with protein trafficking so that newly generated 
cytokines can be trapped inside the cell for intracellular cytokine staining (BFA, Sigma- 
Aldrich, St. Louis, MO) was added to each well at 5pig/ml with total culturing volume 
brought up to 180 ul (226, 227). The culture was incubated at 37°C for 3 more hours 
after addition o f BFA and supernatants were removed from the cells or saved when
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needed, before the cells were fixed and analyzed by intracellular cytokine staining and 
flow cytometry. The total culture incubation time was 20-24 hours in this assay. To 
detect NK and T cell activation, anti-CD3 (FITC), CD56/16 (PE), CD69 (PerCP), and 
IFN-y (APC) antibodies were used in intracellular cytokine staining. To detect pDC 
activation, anti-IFN-o2 (PE, Chromaprobe, Maryland Heights, MO), CD69 (PerCP) and 
CD 123 (APC) antibodies (BD Biosciences, San Diego, CA) were used in the staining. 
Flow cytometry was used to determine the frequency of cytokine secreting cells as well 
as the per-cell-based geometric mean intensity o f fluorescent. In some experiments to 
detect early production o f cytokines, BFA was added 4 hours posterior to stimulation o f 
cells with A/Sydney and the culture was continued at 37°C overnight followed by 
intracellular cytokine staining and flow cytometry analysis. When needed, IFN-a 
neutralizing antibody (polyclonal, Biosource, Miami, FL), IFN-a//3 receptor neutralizing 
antibody (monoclonal, Cellsciences, Inc, Vanton, MA), IFN-y neutralizing antibody 
(monoclonal, R&D Systems, Minneapolis, MN), rIFN-02 (PBL Biomedical Laboratories, 
Piscatawaym NJ), rIFN-y (Invitrogen, Carlsbad, CA) or CpG (ODN2216 at a final 
concentration o f 6 pig/ml, MWG-Biotech, high Point, NC), rIL-12 (p70, PharMingen, San 
Diego, CA) was added to the culture to examine their effects on A/Sydney-induced NK 
or T cell activation.
• Measurement ofpDC, monocyte, and T cell frequencies in PBMC
Live cell staining and flow cytometry were used to examine frequencies o f various cell 
types in PBMC. For measuring pDC frequency, 1 million PBMC were co-stained with 
human lineage markers (including anti-CD3, CD14, CD16, CD19, CD 20 and CD56, 
fluorescein isothocyanate, or FITC-labeled antibodies), CD123 (phycoerythrin, or PE- 
labeled), HLA-DR (peridinin chlorophyll protein, or PerCP-labeled) and CD1 lc  
(allophycocyanin, or APC-labeled) antibodies (BD Biosciences, San Diego, CA) 
followed by 2 washes. For measuring monocyte and T cell frequencies, 1 million PBMC 
were co-stained with anti-human CD14 (FITC), CD3 (PE), CD8 (PerCP), and CD4 (APC) 
followed by 2 washes. Following staining, flow cytometry was used to determine the 
frequency of each cell type.
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• Isolation o f  pDC
Plasmacytoid DC were isolated by using BDCA4 cell isolation kit (Miltenyi Biotec, 
Auburn, CA). Briefly, every up to 108 PBMC were incubated with 300 ji\ o f MACS 
buffer (0.5%BSA and 2mM EDTA in PBS, pH7.2), 100 /d o f FcR blocking reagent and 
100 /d o f anti-BDCA4 magnetic micro-beads at 4°C for 15min followed by one time 
wash with 7.5 ml o f MACS buffer. The cells were then separated by running through MS 
column placed in a magnetic field. BDCA4+ cells (pDC) retained in the column were 
eluted after magnetic field was removed. Isolated pDC and pDC(-) PBMC were re­
suspended in CTL media and counted by automatic counter machine (Coulter Ac * T, 
Beckman Coulter, Miami, FL). A portion o f isolated cells were stained with anti-lineage 
marker (FITC), CD123 (PE), HLA-DR (PerCP) and CD1 lc (APC) antibodies (BD 
Biosciences, San Diego, CA) followed by flow cytometry to examine the purity. The 
purity ranged from 70% to over 95% depending on the amount o f starting PBMC and 
donor. More PBMC was associated with higher purity. Because pDC exist in PBMC at a 
low frequency (0.1-0.5%) and the amount o f PBMC obtained from each individual was 
limited, in some experiments when relatively larger amount o f pDC was needed, PBMC 
from 2  to 8 subjects, depending on the availability o f subjects, in young or old group 
were pooled for pDC isolation. The pooled PBMC comprises equivalent amount of 
PBMC from each subject o f the same age group.
• Isolation o f  monocytes
Monocytes were isolated by using anti-CD 14 micro-beads (Miltenyi Biotec, Auburn, CA). 
Briefly, up to 107 PBMC were incubated with 80 /xl o f MACS buffer and 20 /d o f anti- 
CD14 micro-beads at 4°C for 15min followed by one time wash with 1.5 ml o f MACS 
buffer. The cells were then separated by running through MS column (Miltenyi Biotec, 
Auburn, CA) placed in magnetic field. CD 14+ cells (monocytes) retained in the column 
were eluted after magnetic field was removed. Isolated cells were re-suspended in CTL 
media and counted by automatic counter machine (Coulter Ac * T, Beckman Coulter, 
Miami, FL). A portion o f cells were stained with anti-CD14 (FITC, BD Biosciences, San
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Diego, CA) and CD56 (APC, Miltenyi Biotec, Auburn, CA) antibodies followed by flow 
cytometry to examine the purity
• Isolation N K  cells and T cells
NK cells were isolated by using anti-CD56 magnetic micro-beads or NK cell isolation kit 
II (Miltenyi Biotec, Auburn, CA). By using anti-CD56 micro-beads, up to 107 PBMC 
were incubated with 20 pd o f anti-CD56 micro-beads and 80 pd o f MACS buffer at 4°C 
for 15min followed by one time o f wash with 1.5 ml o f MACS. The cells were then 
separated by running through MS column placed in magnetic field. CD56+ cells (NK) 
retained in the column were eluted after magnetic field was removed. CD56+ NK cells 
and CD56(-) PBMC were re-suspended in CTL media and counted by automatic counter 
machine (Coulter Ac * T, Beckman Coulter, Miami, FL). A portion o f isolated cells were 
stained with anti-CD 14 (FITC, BD Biosciences, San Diego, CA) and CD56 (APC, 
Miltenyi Biotec, Auburn, CA) antibodies followed by flow cytometry to examine the 
purity. By using NK cell isolation kit, up to 107 PBMC were incubated with 10 pd of 
biotin-conjpigated antibodies against CD3, CD4, CD 14, CD 15, CD 19, CD 123 and 
glycophorin and 40 pd of MACS buffer (0.5%BSA and 2mM EDTA in PBS, pH7.2) at 
4°C for 10 min followed by incubation with 20 pd o f anti-biotin micro-beads and 30 pd o f 
MACS buffer at 4°C for 15min. The cells were then washed once with 7.5 ml o f MACS 
buffer and applied to LS column for separation. Positively labeled un-related cells were 
retained in the column and untouched NK cells were enriched in the eluted buffer. 
Isolated cells were re-suspended in CTL media and counted by automatic counter 
machine. A portion of isolated cells were stained with anti-CD3 (FITC), CD56/16 (PE), 
and CD 14 (APC) antibodies (BD Biosciences, San Diego, CA) followed by flow 
cytometry to examine the purity. T cell isolation procedure was similar to that o f NK 
isolation by using anti-CD56 micro-beads except that anti-CD3 instead o f CD56 micro­
beads was used. Anti-CD3 (FITC), CD56/16 (PE), and CD14 (APC) antibodies were 
used for staining to examine the purity.
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• Quantification o f  IFN-a by ELISA
Supernatant from Fastlmmune PBMC or influenza virus-stimulated pDC were examined 
for IFN-a levels using human IFN-a ELISA kit (Biosource, Camarillo, CA). Briefly, 
supernatant at 1:25 dilution and standards were incubated in 96-well plate wells coated 
with capturing antibodies recognizing multi-subspecies o f IFN-a including subtypes A, D, 
K, G, C, J but not B2, F and H. Then detecting antibody (secondary antibody), anti­
secondary antibody conjugated to horseradish peroxidase (HRP) and substrate 
tetramethyl-benzidine (TMB) were used sequentially for the rest o f the assay following 
manufacturer’s instruction. The plates were read at 450 nm by PowerReportsx ELISA 
reader and analyzed with KC4 (version 3.0) software (Bio-Tek Instruments, Inc., 
Winooski, VT).
• Stimulation ofpD C  o f  young and older subjects
To compare IFN-a level secreted by pDC between young and older people, 0.05 million 
pDC isolated from pooled PBMC from 2-6 young subjects or 4-8 older subjects were 
stimulated with 1 /d o f influenza virus in 96-well U-bottom plate at 37°C in the absence 
o f BFA. Supernatants were collected the next day and examined for IFN-a level by 
ELISA.
• Examination o f  effect o f  supernatant on N K  cells
One million PBMC were stimulated with or without 1 /d o f influenza virus under regular 
Fastlmmune (FI) assay culture set-up conditions except for in the absence o f BFA. 
Supernatants from cultured wells were collected the next day and utilized to stimulate 
autologous NK cells isolated from PBMC. Each well containing 0.2 million isolated NK 
cells in 20 /d o f CTL media in conjunction with 130 /d o f cultured supernatant was 
incubated at 37°C overnight before BFA was added to the culture. All other conditions 
were same as in regular FI assay.
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• Transwell experiment
Three million CD56 (-) PBMC were placed in regular 24-well plate and stimulated with 
or without 20 pi o f influenza virus in 700 /d o f CTL media. CD56+ NK cells were 
placed in transwell (Fisher Scientific, Pittsburgh, PA) at 0.2 million per well in 50 pi of 
CTL media. As a control, equal amount o f NK cells were mixed with CD56 (-) PBMC in 
a regular well. The plate was incubated at 37°C overnight followed by regular FI 
procedures for intracellular cytokine staining and flow cytometry to detect IFN-y 
secretion by CD56+ NK cells. Anti-IFN-y (FITC, BD Biosciences, San Diego, CA), 
CD69 (PE, BD Biosciences, San Diego, CA) and CD56 (APC, Miltenyi Biotec, Auburn, 
CA) antibodies were used in the staining.
• Examination o f  NKp44 and NKp46 expressions on NK cells in PBMC
One million resting PBMC or PBMC stimulated with or without 2 pi o f influenza virus in 
regular FI procedure but in the absence o f BFA were examined for NKp44 and NKp46 
expressions by live cell, indirect staining. Briefly, PBMC were stained with mouse-anti- 
human NKp44 antibody (R&D Systems, Minneapolis, MN) followed by secondary 
antibody, goat-anti-mouse IgG (FITC, Jackson Immuno Research, West Grove, PA), 
staining. After blocking with normal mouse serum, the cells were co-stained with anti­
human NKp46 (PE, R&D Systems, Minneapolis, MN), CD3 (PerCP) and CD 19 (APC) 
antibodies (BD Biosciences, San Diego, CA) followed by two washes. Flow cytometry 
was used to determine the intensity o f fluorescent level o f NKp44 and NKp46 on NK 
cells identified by excluding CD3+, CD 19+ lymphocytes and morphologically different 
monocytes from PBMC.
• Examination o f  influenza HA expression on monocytes in PBMC
One million resting PBMC or PBMC stimulated with or without 1 pi o f influenza virus as 
in regular FI procedure but in the absence o f BFA were examined for HA expression on 
monocytes by live cell, indirect staining. Briefly, PBMC were stained with mouse anti-
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HA (for H3 subtype o f influenza A virus only, Chemicon International, Inc, Temecula, 
CA) followed by secondary antibody staining with goat-anti-mouse IgG (FITC, Jackson 
Immuno Research, West Grove, PA). After blocking with normal mouse serum, the cells 
were co-stained with anti- CD69 (PerCP) and CD 14 (APC) antibodies (BD Biosciences, 
San Diego, CA) followed by two times of wash. Flowcyotmetry was used to determine 
the intensity o f fluorescent level o f HA and CD69 on CD 14+ monocytes.
• Experiment o f  differential effect ofyoung or aged pD C on N K  cell activation
Plasmacytoid DC of young and older subjects, namely pDC(Y) and pDC(O) respectively, 
were isolated from pooled PBMC from 2-3 donors. One million PBMC of each young or 
older subject or 1 million pDC(-) pooled PBMC were stimulated with 1 pi o f influenza 
virus with or without addition o f 0.01 million pDC(Y) or pDC(O). That equal amount of 
pDC(Y) and pDC(O) was added to the culture was verified by measuring the frequency 
of pDC by live cell staining and flow cytometry with pDC identification antibodies 
described earlier. Other conditions for culture set-up and detection o f NK cell activation 
were same with those in regular FI procedures. Three independent experiments involving 
a total o f 8 young and 8 older subjects were performed.
• Crossover experiment o f  monocytes between young and older subjects
CD 14+ monocytes o f young and older subjects, namely Mono(Y) and Mono(O), 
respectively, were generated by pooling equal amount o f PBMC from 2-3 individual.
One million CD14(-) PBMC of each young or older subject were stimulated with 1 pi of 
influenza virus with or without addition of 0.1 million CD14+ Mono(Y) or pDC(O). 
Equal amount o f Mono(Y) and Mono(O) added to the culture was verified by measuring 
the frequency o f added CD 14+ monocytes using live cell staining and flow cytometry 
with anti-CD 14 antibody. Other conditions for culture set-up and detection o f NK cell 
IFN-y production were as same as in regular FI procedures. Four independent 
experiments involving a total o f 10  young and 10  older subjects were performed.
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II. 5 Statistical Analysis
All statistical analysis was done by using SPSS software. Two-tailed non-parametric 
Mann-Whitney test or Sign test was used to compare differences between groups when 
variables were not suggested to follow normal distribution by normality test or sample 
size was relatively small. Two-tailed t test or ANOVA was used when sample size was 
relatively big and normality test suggested normal distribution.
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III. RESULTS
III. 1 Down-regulation o f NK Cell Activation in PBMC in Response to Influenza Vims in 
Older People
• N K  cell activation determined as IFN-y production in response to influenza virus 
was down-regulated in older subjects
Knowing NK cells secrete a significant amount o f IFN-y in response to influenza vims, 
we first wanted to know whether there was a difference in IFN-7  production NK cells in 
influenza vims-stimulated PBMC between young and older people. We used an 
activation priming marker CD69 in conjunction with IFN-y to monitor NK cell activation. 
By comparing IFN-y secretion between 18 healthy young and 25 healthy older subjects 
by Fastlmmune (FI) assay, we found upon influenza viral stimulation o f PBMC, both the 
frequency o f CD69+IFN-Yt‘ NK cells and the per-cell-based intensity o f IFN-y were 
significantly less in older subjects than those in the young subjects (p<0.001, Figure 5A,
B and C). The frequency o f CD69+IFN-Y+ NK cells and per cell-based IFN-y intensity 
among total NK cells was 14.9+2.2% (mean+s.e.m.) and 320+156 (mean+s.d.), 
respectively in the young subjects and 2.8+1.8% (mean+s.e.m.) 232+101 (mean+s.d.), 
respectively in the older subjects (Figure 5B left). Significant lower frequency o f 
activated NK cells was also found in older subjects when total lymphocytes instead o f 
NK cells were used as the denominator (0.85+0.17% in the young and 0.24+0.13% in the 
old, mean+s.e.m., p=0.002, Figure 5B right), indicating the aging-related up-regulation of 
overall NK cell frequency in lymphocytes (6.4+3.2% in the young and 12.0+3.2% in the 
old, mean+s.d., p=0.001) was not adequate to compensate the reduction in number o f NK 
cells secreting IFN-y m response to influenza vims in older people (S. Figure 1). We 
could not find significant difference in CD69 intensity in either CD69+IFN-7+ or 
CD69+EFN-Y- NK cells (S. Figure 2A) or in CD69+IFN-Y- NK cell frequency (S. Figure 
2A) in total NK cells between young and older subjects, indicating early signal 
transduction event in NK cell activation in influenza-vims stimulated PBMC is relatively 
well preserved with aging.
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Figure 5. Down-regulation of IFN- 7  production in NK cells in PBMC in response to 
influenza virus in older subjects
One million PBMC from each of 15 healthy young and 25 healthy older subjects were 
stimulated with 1 /il of influenza virus in 96-well plate overnight. Fastlmmune assay and flow 
cytometry was used to determine the frequency of CD69+IFN-/y+ NK cells. A, CD56+orl6+ 
NK cells were gated out of lymphocytes and analyzed for CD69 and IFN-y expression by flow 
cytometry. An example of expression of CD69 and IFN-y in NK cells in a young and an older 
subject was presented. B, comparison of CD69+IFN-y+ NK cell frequency in total NK cells 
(left graph in panel B) and lymphocytes (right graph in panel B) between young and older 
subjects. Horizontal bars represent the mean. C, Average intensity of IFN-y in CD69+IFN-y+ 
NK cells in young and older subjects. Error bars represent standard deviation.
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• Down-regulated NK cell IFN-y production in response to influenza virus in older 
subjects was associated with reduced T  cell activation and IFN-a secretion in 
PBMC
We next wanted to examine whether down-regulated NK cell activation in older subjects 
in response to influenza stimulation was associated with changes in other factors in 
PBMC. We examined a subset o f the same samples studied in Figure 4 for supernatant 
level o f IFN-O! by ELISA and T cell (CD3+) activation by flow cytometry and found both 
IFN-a levels in supernatant and the frequency of CD69+IFN-yf T cells were significantly 
reduced in older subjects compared to the young subjects (Figure 6 , p=0.002 and p<0.001 for 
IFN-a level and activated T cell frequency, respectively). The supernatant IFN-a levels 
and the frequency of CD69+IFN-yf T cells among total T cells were 12.3+4.8 ng/ml 
(mean+s.d.) and 1.42+0.36% (mean+s.e.m.), respectively, in the young subjects, 
compared to 7.5+4.5 ng/ml (mean+s.d.) and 0.30+0.26% (mean+s.e.m.), respectively, in 
the older people. Then we calculated the correlation coefficients, which measure the 
linear relationship between frequency of activated NK cells, supernatant IFN-a level and 
frequency of activated T cells. We found the frequency of CD69+IFN-'y+ NK cells in total 
NK cells moderately correlated with IFN-a level in supernatant (r=0.56) and highly correlated 
with the frequency o f CD69+IFN-y+- T cells in total T cells (r=0.86) (Table II), indicating 
down-regulated NK cell IFN-y production in response to influenza virus in older subjects 
was associated, though not necessarily in a causal/effect relationship, with reduced T cell 
activation and IFN-a secretion in PBMC. The fact that poor correlation between 
supernatant IFN-a level and frequency of IFN-Y+ T cells (rO .35) indicates the 
relationship between these two variables is at least not linear in our experimental system 
(Table II).
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Figure 6 . Reduced level of IFN-a and lower frequency of IFN-7 -producing T cells in 
PBMC in response to influenza virus in older subjects
A subset of the same samples studied in Figure 4 (One million PBMC from 12 healthy 
young and 18 healthy older subjects stimulated with 1 /xl of influenza virus) was analyzed 
for T cell IFN-y production and IFN-a secretion. Supernatants saved from the same wells 
that were examined for NK and T cell activation were analyzed for IFN-a by ELISA. A, 
supernatant IFN-a level in young and older subjects. B, frequency of CD69+IFN-y+ T 
cells in total T cells in young and older subjects. T cells were identified by CD3+ 
antibody. Horizontal bars represent the mean.
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Table II. Correlation between frequency of activated NK cells*, supernatant IFN-a level, 
and frequency o f activated T cells* in young and older subjects
Age groups Young and old Young only Old only
and variables 
to analyze
IFN -a Frequency of 
level activated T cells
IFN -a Frequency o f 








0.56 0.86 0.49 0.77 0.32 0.95
IFN-a level 0.35 0.09 0.27
* Frequencies o f activated NK cells or T cells are expressed as the percent o f total NK or 
T cells that are CD69+IFN-yF.
III.2 IFN-a and IFN- 7  Regulated NK Cell IFN-y Production in Response to Influenza 
Virus
• Neutralizing antibodies against IFN-a or IFN-a receptor down-regulated N K  cell 
activation in response to influenza virus
To find whether down-regulation o f IFN-7  production in NK cells was a potential 
outcome o f down-regulation o f IFN-a secretion in PBMC upon influenza viral 
stimulation, we first asked how important IFN-a was in regulating NK cell IFN-7  
production in response to influenza virus. By performing FI assay with adding anti-IFN- 
a  or anti-IFN-ojS receptor neutralizing antibodies to PBMC from healthy young subjects, 
we observed NK cell activation determined as the frequency o f CD69+IFN-y+- NK cells 
in total NK cells were down-regulated in a dose-dependent manner with the increased 
dose o f either antibody (Figure 7). There was no significant difference in NK cell 
activation between the treatments without antibody and with the control antibody 
containing equivalent amount o f IgG to that in the well bearing highest neutralizing unit 
o f antibody. Our data clearly indicates the importance o f IFN-a in mediating NK cell 
IFN-7  production specifically in response to influenza virus, supporting that age-related
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changes in IFN-a production, if  any, bears the potential to contribute to the age-related 
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Figure 7. Neutralizing antibodies against IFN-o: or IFN-cF/3 receptor down-regulated NK 
cell activation in response to influenza virus in PBMC
One million PBMC from 9 healthy young subjects were stimulated with 1 /zl of influenza 
virus in the presence of different doses of IFN-o: or IFN-o: receptor netralizing antibodies. 
Fastlmmune assay and flow cytometry was used to determine the frequency of 
CD69+IFN-'y+ NK cells. A, with anti-IFN-G! antibody. B, with anti-rFN-o: receptor 
antibodv. Horizontal bars represent the median.
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• CpG up-regulated N K  cell activation in response to influenza virus
To further confirm the role o f IFN-a in up-regulating NK cell IFN-Yprodution in 
response to influenza virus, we used CpG ODN2216, a TLR-9 agonist that induces IFN-a 
production in pDC to examine whether up-regulation o f IFN-a would enable NK cells in 
PBMC to produce more IFN-y in response to influenza virus. By performing regular FI 
assay with or without addition o f CpG to influenza viral stimulated PBMC from healthy 
young subjects, we found in the presence o f CpG both the frequency of IFN-a+ cells and 
per-cell-based IFN-a intensity in CD123hi (a manifest o f pDC) but not CD1231ow 
(related to monocytes and mDC) cells were significantly increased (p<0.05, Figure 8A). 
At the same time the frequency o f activated NK cells was up-regulated (p<0.05, Figure 
8B). This result, consistent with that in Figure 7, confirms the significant role o f IFN-a 
in mediating NK cell IFN-y production in PBMC in response to influenza virus.
• Effects o f  anti-IFN-y neutralizing antibody on NK cell IFN-y production in PBMC  
in response to influenza virus
In addition to IFN-a, we also wanted to examine the role o f IFN-y in NK cell activation 
to influenza stimulation. Similarly, we performed regular FI assay, in which different 
doses o f anti-IFN-Y neutralizing antibody were added to influenza viral stimulated PBMC 
from healthy young subjects, and monitored frequency o f IFN-y producing NK cells. At 
concentrations o f 0, 0.25, and 0.5 pg o f antibody per 150 p\ o f reaction volume, there was 
a trend o f the dose-dependent reduction in the frequency of activated NK cells, but it 
didn’t reach the significant level o f o=0.05 (Figure 9). It should be noted that an 
antibody dose-dependent down-regulation o f NK cell activation occurred in all three 
subjects with higher (3.3-7.1%) baseline (in the absence of antibody) levels but not in 
subjects with relatively low (0.1 -0.7%) baseline levels o f NK cell activation. This 
seemed to suggest that baseline level o f IFN-y lower than certain limit may not respond 
effectively to the neutralizing antibody. Increasing sample size and dividing subjects 
based on their baseline responsive level to influenza virus may help clarify the results. In 
conclusion, the importance o f the role o f IFN-y in regulating NK cell IFN-y production
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Figure 8. Effects of CpG on production of IFN-a and NK IFN-y in PBMC
One million PBMC from 6  (A) or 3 (B, the 3 subjects in B were also participating in A) healthy 
young subjects were stimulated with 1 /xl of influenza virus in the presence of 6  ng/ml of CpG 
ODN2216. CpG was added 4 hours after initiation of influenza infection. Fastlmmune assay and 
flow cytometry was used to determine the intensity of IFN-a, frequency of IFN-ofrCD123hi or 
low cells and CD69+IFN-y+ NK cells. A, IFN-a+ cell frequency and IFN-a intensity in CD123hi 
or low cells in the presence or absence of CpG. B, activated NK cell frequency in the presence or 
absence of CpG. Horizontal bars represent the median.
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Figure 9. Effects of neutralizing antibody against IFN-y on NK cell IFN-y production in 
response to influenza virus in PBMC
One million PBMC from 6  healthy young subjects were stimulated with 1 /d of influenza virus 
in the presence of different doses of IFN-y neutralizing antibody. Fastlmmune assay and flow 
cytometry was used to determine the frequency of CD69+IFN-y+ NK cells. Horizontal bars 
represent the median.
could not be verified by the usage o f anti-IFN-y neutralizing antibody.
• IFN-y facilitated monocytes to activate N K  cells in response to influenza virus
To clarify the role o f IFN-y in NK cell activation regulation, we decided to use isolated 
cells to avoid actions taken at one time by too many regulatory factors in PBMC in 
response to influenza stimulation. Because rIFN-y alone or in conjunction with influenza 
virus could not activate NK cells to produce IFN-y while monocytes are able to be 
activated by IFN-y and capable to produce NK-activating cytokines, such as IFN-a, IL-18, 
and IL-15, a cytokine that shares similarity with IL-2 in stimulating NK activation, we 
isolated monocytes and NK cells from resting PBMC from healthy young subjects by 
using CD14+ micro-beads and untouched CD56/16 NK cell isolation kit, respectively 
and examined the effect o f rIFN-y on NK cell activation to influenza viral stimulation in 
the presence or absence o f monocytes. In the presence o f monocytes, influenza virus in 
conjunction with rIFN-y effectively activated NK cells and induced NK cell IFN-y 
production in a rIFN-y dose-dependent manner (Figure 10A and B). These results 
confirmed the important role o f IFN-y in regulating NK cell IFN-y production in response
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to influenza virus and provided the possibility that the age-related down-regulation in NK 
IFN-y production might be due to age-related reduction, if  any, in IFN-y production prior 
to activation o f NK cells in PBMC.
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Figure 10. Recombinant IFN-y positively regulated NK cell activation in the presence of 
monocytes in response to influenza virus
One fifth million isolated monocytes ( by CD 14 beads) and 0.2 million autologous NK cells 
(including both CD56+ or CD 16+ NK but untouched) from 2 or 3 healthy young subjects 
were stimulated with 1 gl of influenza virus in the presence or absence of different doses of 
rlFN-Y- FI assay and flow cytometry was used to determine the frequency of CD69+IFN-yr 
NK cells. A. NK cell activation in the presence or absence of influenza virus or 100 ng/ml 
of rlFN-Y B, NK cell activation to influenza virus in the presence of different doses of 
rlFN-Y
III. 3 Plasmacytoid DC and T cell Regulated NK Cell Activation in Response to 
Influenza Virus
We have shown previously that both IFN-a and IFN-y play an important role in influenza 
virus stimulated NK cell IFN-y production. Next we wanted to explore the role o f major 
cell types producing these cytokines. Plasmacytoid DC secrete significant amount of 
IFN-a in response to influenza stimulation (228). We decided to remove pDC from 
resting PBMC from healthy young subjects by using BDCA4 micro-beads and examine 
how reduction o f pDC influence NK cell activation in response to influenza virus by 
performing FI assay. BDCA4 is a cell adhesion molecule and known to be exclusively 
expressed on pDC in resting PBMC. We found removal o f pDC from PBMC
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significantly down-regulated NK cell activation determined as the frequency of 
CD69+IFN-yf NK cells over total NK cells and adding removed pDC back to the pDC- 
reduced PBMC tended to restore NK cell activation though the restoration did not reach 
the significant level at o=0.05 (Figure 11 A, left). In fact, pDC dose-dependent increment 
o f NK cell activation was observed, though the number o f subjects tested was limited 
(Figure 11 A, right), supporting that pDC could be important in NK cell activation 
regulation.
In addition to pDC we wanted to know how T cells influence NK cell activation for T 
cell is the only cell type, in addition to NK cells to secrete significant amount o f IFN-y 
upon activation. We decided to remove T cells from resting PBMC from healthy young 
subjects by using CD3 micro-beads and examine how reduction o f T cells influence NK 
cell activation in response to influenza virus by performing FI assay. We could not find 
significant difference in NK cell activation by influenza virus between PBMC and T cell- 
reduced PBMC. This could be due to some non-specific of the isolation procedure effect 
on NK cells or other cells regulating NK activity. Instead of this, when the removed T 
cells were added back to the T cell-reduced PBMC, there was a T cell dose-dependent 
increment in NK cell activation (Figure 1 IB), indicating T cells were playing a 
significant role in mediating NK cell activation in response to influenza virus.
III.4 Aging Affected pDC and T Cell Frequencies and Cytokine Productions as well as 
pDC-mediated NK Cell IFN-y Production
• Plasmacytoid DC frequency in PBMC and ability to secrete IFN-a were down- 
regulated in older subjects
In previous experiments we confirmed IFN-a was a critical mediator for NK cell 
activation in response to influenza virus (Figures 7 and 8) and IFN-a levels were 
significantly reduced in PBMC in response to influenza stimulation in older subjects 
(Figure 6 A). IFN-a in PBMC in response to influenza virus was significantly contributed 
by pDC therefore it was o f importance to know how aging influence pDC with respect to
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Figure 11. Effects of pDC or T cells on NK cell IFN- 7  production in response to influenza 
virus in PBMC
A. Effect of pDC. One million PBMC or pDC-removed PBMC from 12 healthy young 
subjects were stimulated with 1 /xl of influenza virus with or without addition of isolated pDC. 
Fastlmmune assay and flow cytometry was used to determine the frequency of CD6 9 +IFN-7+ 
NK cells. Left, effect of reducing pDC or adding pDC back to pDC-removed PBMC. Right, 
pDC dose-dependent effect. One part of pDC dose was comparable to pDC amount isolated 
from 1 million PBMC. B. Effect of T cells. Half million T-cell reduced PBMC from 4 
healthy young subjects were stimulated with 1 jul of influenza virus with or without addition of 
isolated T cells. Fastlmmune assay and flow cytometry was used to determine the frequency 
of CD6 9 +IFN-7 + NK cells. One part of T cell dose was comparable to T cell amount isolated 
from 1 million PBMC. Horizontal bars represent the median.
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its availability and function. To examine whether there was a difference in pDC 
frequency in PBMC between young and older people, we performed live cell staining on 
PBMC from 52 healthy young and 75 healthy older subjects. It was observed that the 
frequency o f pDC in PBMC in older subjects was significantly lower than that in the 
young subjects (p<0.05, Figure 12). The median o f pDC frequency in the young subjects 
was 0.14%, which was in contrast to the median, 0.10%, in older people. The absolute 
median value o f pDC frequency was 0.04% different between young and older subjects, 
which reflected a 29% numerical deduction in the older subjects relative to the young. 
Further, we wanted to examine whether there was an intrinsic functional defect in pDC 
from older adults. We isolated pDC from pooled PBMC from young or older subjects, 
stimulated them with influenza virus and monitored IFN-a secretion in supernatant by 
ELISA. Significantly lower level o f IFN-a secretion was found in older subjects (2.9- 
15.6, median=7.6 ng/ml, 37.6+13.4% of reduction, mean+SD) than that in the young 
control (5.7-19.2, median=10.9 ng/ml, p<0.05, Figure 13). These results suggests that 
down-regulation o f both the frequency and intrinsic function o f pDC leads to reduced 
production o f IFN-a and contributes to NK cell activation down-regulation in response to 
influenza virus in older people.
P < 0 . 0 5
Young Old
Figure 12. Comparison of frequency of pDC in PBMC between young and older people
Plasmacytoid DC frequency in PBMC between 52 healthy young and 75 healthy older adults 
was compared. PBMC were co-stained with anti-lineage marker (FITC), CD123(PE), HLA- 
DR(PerCP) and CD1 lc(APC) antibodies and identified as cells characterized as 
CD123+HLA-DR+ and lineage marker-CDl lc- by flow cytometry.
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Figure 13. Plasmacytoid DC isolated from older subjects secreted less IFN-a upon influenza 
infection
Plasmacytoid DC were isolated by using BDCA-4 magnetic beads from pooled PBMC of young 
(2-6 donors per pool) or older (4-8 donors per pool) volunteers. Isolated pDC were infected with 
1 /d of influenza virus in 96-well plate. Supernatant was collected the next day and examined for 
IFN-a by ELISA. Data from 5 independent experiments involving 22 young and 30 older subjects 
are shown. Elongated bars represent the median.
• T  cell frequency and function decrease with age
The age-related changes in T cell function have been one o f the major focuses in the field 
o f immunology and aging. Data from our early research showed T cell, particularly 
CD4+ and CD8+ memory T cell responses to influenza infection and vaccination 
declined in elderly people (174). This is consistent with our current data that NK cell 
activation correlated with T cell activation and both were down-regulated with in older 
people (Figure 1 and 2B, and II). Here we simply compared the quantities o f PBMC, T 
cells and monocytes in human peripheral blood between 12 healthy young and 23 healthy 
older subjects and observed PBMC yield, pan T cell, CD4+ T cell and CD8+ T cell 
quantities in blood were significantly lower in older subjects than those in the young 
people (Table III). On the other hand, significant differences in numbers o f CD14+ 
monocytes between the two age groups was not detected (Table III).
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Table III. Comparison o f PBMC, T cell and monocyte numbers* in human peripheral 














1.25 + 0.43 0.84+0.30 0.57+0.21 0.23+0.076 0.059+0.047
Old
(n=23) 0.85 + 0.30 0.49+0.23 0.36+0.17 0.13+0.099 0.044+0.029
P value 
(2-tail t- test) 0.003 0.0006 0.0038 0.0031 0.2693
P value (2-tail 
Mann-Whitney 
test) <0.001
* PBMC number was calculated by dividing total amount of PBMC obtained after blood 
processing by total volume of blood from which PBMC were isolated. CD3, CD4, CD8 positive 
T cells or CD 14 positive monocyte numbers were caluculated by multiplying PBMC number by 
frequency of each cell type in PBMC. The frequency of each cell type in PBMC was determined 
by live cell staining of resting PBMC and flow cytometry.
• Plasmacytoid DC from  young subjects better facilitated N K  cell activation than 
pD C from  older subjects in response to influenza virus
Previous experiments in this study suggested that pDC were important in activating NK 
cells in response to influenza stimulation. We asked whether pDC from young or older 
people differentially mediate NK cell activation by influenza virus. We performed FI 
assay, in which equal amounts o f pDC isolated from PBMC pool from either young or 
older subjects were added to individual PBMC followed by stimulation with influenza 
virus. We found pDC isolated from young adults better functioned significantly than 
pDC isolated from older subjects in stimulating NK cell activation in both young and 
older subjects (p<0.05, Figure 12). The percent o f NK cells that were activated in the 
presence o f young or aged pDC in the young subjects ranged from 0.4-5.2% with 
median=2.1% and 0.4-4.9% with median=1.3%, respectively. Percent o f NK cells that 
were activated in the presence of young or aged pDC in the older subjects ranged from
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
49
0.1-6.2% with m edian=l.l%  and 0.03-2.8% with median=0.6%, respectively. We didn’t 
observe an up-regulation o f NK cell activation when additional pDC, whether young or 
aged were added to PBMC as compared to that without additional pDC. There was a 
trend, though not having reached the significant level that NK cell activation was lower 
in older subjects than that in the young when PBMC from young and older subjects were 
treated the same way (Figure 14). It was surprising that the difference in NK cell 
activation in influenza stimulated PBMC between young and older subjects was not as 
significant as we observed before (Figure 5B). Beside differences due to donor variation 
and experimental error, this could be a consequence o f smaller sample size and/or smaller 
age difference between young and older subjects in current study than that in the previous 
(43 subjects with age range o f 23-40 years, mean=29 years for the young and 65-81 years, 
mean=74 years for the older in previous study compared with 17 subjects with age range 
o f 21-44, mean=33 year for the young and 60-84 years, mean=69 years for the older 
subjects in current study). In general, these results are consistent with what we have 
observed in the earlier part o f this study, together indicating down-regulated pDC 
function contributes to down-regulated NK cell activation in response to influenza virus 
in older subjects.
III. 5 Soluble Factors vs. Cell-cell Contact in Regulating NK Cell IFN-y Production
• NK cells were activated by soluble factors in the absence o f  contact with other 
cells
To investigate to what extent soluble factors vs. cell-cell contact participates in mediating 
NK cell IFN-y production in response to influenza stimulation we first asked whether NK 
cells were activated by soluble factors alone. To exclude the influence o f cellular contact, 
we used supernatants generated from influenza virus -stimulated PBMC to stimulate 
autologous NK cells isolated from PBMC by using CD56 micro-beads. As shown in 
Figure 15, both CD69 intensity in NK cells and the frequency o f IFN-y producing NK 
cells in the presence o f influenza virus-stimulated supernatant (9.3 to 16.6, median =11.7 
for CD69 intensity, and 0.14-20%, median=4.5% for IFN-yf NK frequency) were
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significantly higher (p<0.05) than those in the presence o f non-stimulated supernatant 
(6.0 to 8.0, median=7.1 for CD69 intensity, and 0-0.7%, median=0.08% for IFN-yf NK 
frequency) or media control (5.7 to 7.7, median=6 .8  for CD69 intensity, and 0.07-1.7%, 
median=0.17% for IFN-7+ NK frequency, Figure 15A and B). This clearly indicated NK 
cells were able to be activated by soluble factors only without cell-cell contact between 
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Figure 14. Differential effects of pDC from young or older subjects on NK cell activation in 
response to influenza virus
Plasmacytoid DC were isolated by using BDCA-4 magnetic beads from pooled PBMC from either 
young (2-3 donors per pool) or older (2-3 donors per pool) volunteers. ). One a hundredth million 
isolated pDC were co-cultured with 1 million individual PBMC in the presence of 1 /xl of influenza 
virus in 96-well plate. FI assay and flow cytometry was used to determine the frequency of 
activated NK cells. The graph represents data from 4 independent experiments involving 9 young 
and 8 older subjects. Horizontal bars represent the median.
• Cell-cell contact contributes to N K cell activation in response to influenza viral 
stimulation
Results from Figure 13 suggested that NK cells are activated in the absence o f contact
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Figure 15. NK cell activation by supernatant generated from influenza virus-stimulated PBMC
One million PBMC were stimulated with 1 /xl of influenza virus as did in regular FI assay except 
for no addition of BFA. Supernatant was collected the next day and used to stimulate NK cells 
isolated by CD56 micro-beads without addition of influenza virus. Supernatant and NK cells 
were donor-matched. A regular FI assay and flow cytometry was used to detect NK cell 
activation manifested by IFN-y secretion in CD69+ cells. A, frequency of CD69+IFN-y+ NK 
cells. B, CD69 intensity in NK cells. Six healthy young subjects were recruited to this study. 
Horizontal bars represent the median.
with other cells. On the other hand, in the environment o f PBMC, contact with other, 
particularly antigen presenting cells may provide NK cell a better opportunity to be
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activated to a higher level than that by soluble factors alone. To examine whether 
cellular contact plays a significant role in NK cell activation, we performed a transwell 
experiment, in which isolated CD56+ NK cells were placed in transwells and prevented 
from contact with CD56-removed PBMC placed in the regular well and stimulated with 
influenza virus. Soluble factors can freely transport between the transwells and regular 
wells through semi-permeable membranes. It was observed when cell-cell contact was 
prevented, NK cell activation was significantly down-regulated, reflected by a reduction 
in both the percentage o f CD69+IFN-y+ NK cells and CD69 intensity in overall NK cells 
compared to the contact control (Figure 14). In contrast to 2-3.9% of NK cells activated 
by contact with CD56(-) PBMC, only 0.05-0.3% o f NK cells were activated without 
contact (p<0.05). The intensity o f CD69 was 5.3-11.6 with contact and 4.8-9.2 without 
contact (p<0.05). These results clearly indicated that cell-cell contact regulation is 
playing a vital role in activating NK cells in response to influenza stimulation.
III. 6 Influences o f aging on expression o f receptor or ligand involved in cell-cell 
recognition between NK cells and antigen presenting cells
• Differential expressions ofNKp44 and NKp46 receptors on N K  cells in PBMC  
between young and older subjects
NK cells recognize and elicit cytotoxicity towards viral infected antigen presenting cells, 
particularly monocytes via conventional and unconventional ways. The conventional 
way involves interaction between NK inhibitory receptors and MHC I molecule on 
monocytes and an unconventional way involves recognizing viral proteins, HA protein 
for influenza virus, expressed on infected APC by NK activating receptors NKp44 and 
NKp46. Since cell-cell contact significantly influences IFN-y production in NK cells in 
PBMC in response to influenza virus (Figure 16), it is o f interest to examine how aging 
influences the expression o f the activating receptors specifically recognizing influenza 
HA protein. The expression pattern o f NKp44 and NKp46 was different in NK cells. 
The former didn’t show distinct NKp44 positive or negative cell populations, therefore 
was analyzed only the overall intensity on NK cells. The latter exhibited distinct NKp46
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Figure 16. Down-regulation of NK cell activation in response to influenza virus without cellular 
contact
One million CD56-reduced PBMC were stimulated with 20 /xl of influenza virus. 0.2 million 
CD56+ NK cells isolated from PBMC was placed in transwell or mixed with CD56-reduced PBMC 
in regular well as the control. FI assay and flow cytometry was used to detect NK cell activation 
manifested by IFN-y secretion in CD69+ cells. A, frequency of CD69+IFN-y+- NK cells. B, CD69 
intensity in overall NK cells. Elongated bars represent the median.
positive or negative cell populations, therefore we analyzed both the intensity o f NKp46+ 
NK cells and the frequency o f NKp46+ cells in total NK cell populations. We observed 
that both the NKp44 and NKp46 expression were significantly increased by influenza 
viral stimulation, reflected by the increased intensity o f NKp44 and NKp46 in both age 
groups (p<0.05, 0.01 or 0.001, Figure 17A) but not the frequency o f NKp46+ NK cells, 
although the frequency of NKp46+ NK cells increased in both mock-stimulated and 
influenza virus-stimulated PBMC as compared to resting PBMC (Figure 17B). The 
values o f the measurements are listed in Table IV. Opposite to that lower frequency of 
IFN-y producing NK cell frequency was detected in the elderly than young subjects, 
higher intensity o f NKp44 on resting NK, media (mock)-stimulated NK and influenza- 
stimulated NK cells (Figure 17A, upper plot) and higher frequency NKp46+ NK cells 
after influenza stimulation (Figure 17B, lower plot) were found in the older subjects than 
the young subjects. Considering older people possessed higher frequency o f total NK 
cells in lymphocytes than young subjects (S. Figure 1), it was not surprising that the
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frequency of NKp46+ NK cells in lymphocytes, whether under resting, mock-stimulated 
or influenza-stimulated conditions, was higher in the older subjects than that in the young 
(Figure 17B). These results indicated that NKp44 and NKp46 might not be the 
contributing factors for down-regulated NK cell activation with respect to IFN-7  
production in older people, but a valid conclusion can not be drawn unless functional 
studies show that aging does not affect the functions o f these receptors.
• Differential expression o f  influenza HA protein on monocytes in influenza virus 
infected PBMC between young and older subjects
NKp44 and NKp46 recognize influenza HA protein expressed on monocytes. We 
wonder whether there is differential expression o f HA on monocytes between young and 
older subjects upon influenza viral infection. As expected, HA expression on CD 14 
monocytes was significantly elevated in response to influenza infection as compared to 
the mock (media) infection in both young and older subjects (Figure 18A, left) with HA 
intensity ranging from 43-55 (median=49) and 50-104 (median=69) for mock-stimulation 
and influenza-stimulation, respectively, in the young subjects and 36-65 (median=52) and 
54-114 (median=6 6 ) for mock- and influenza-stimulation, respectively, in the older 
subjects. Consistently, CD69 expression on the monocytes was increased from 13.1-26.8 
(median=18.8) to 19.4-48.6 (median=25.7) after influenza viral stimulation in the young 
subjects and from 13.9-26.5(median=18.4) to 22.2-50.6 (median=36.5) after influenza 
viral stimulation in the older subjects, confirming monocytes were activated by influenza 
virus. However, we could not detect differences in either the absolute values o f HA 
intensity, CD69 expression on monocytes (Figure 18 A) or the fold increase in them in 
response to influenza viral infection (Figure 18B) between young and older subjects.
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Figure 17. Comparison of NKp44 and NKp46 expression between young and older subjects
Resting, media (mock)-activated or influenza-activated PBMC from 12 healthy young and 24 healthy 
older subjects were measured by live cell staining and flow cytometry for NKp44 and NKp46 
expression. The stimulation procedure followed regular FI culture set-up procedures except for using 
2/d of influenza virus and adding no BFA. The cells were cultured for 18—20 hours before being 
stained. A, intensity of NKp44 (top) or NKp46 (bottom). B, Frequency of NKp46+ NK cells in 
overall NK cells (top) or in overall lymphocytes (bottom). Horizontal bars represent the mean.
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Figure 17 (cont.)- Comparison of NKp44 and NKp46 expression between young and older subjects
Resting, media (mock)-activated or influenza-activated PBMC from 12 healthy young and 24 healthy 
older subjects were measured by live cell staining and flow cytometry for NKp44 and NKp46 
expression. The stimulation procedure followed regular FI culture set-up procedures except for using 
2/d of influenza virus and adding no BFA. The cells were cultured for 18—20 hours before being 
stained. A, intensity of NKp44 (top) or NKp46 (bottom). B, Frequency of NKp46+ NK cells in 
overall NK cells (top) or in overall lymphocytes (bottom). Horizontal bars represent the mean.
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Table IV. Expressions o f NKp44 and NKp46 on NK cells in PBMC *
Intensitv of NKd44 Intensitv of NKd46
NKp46+ NK% in 
NK
NKp46+ NK% in 
inlvmohocvtes
Activation




8.1(1.6) 10.6(3.1) 99(26) 100(34) 70(13) 71(13) 10(5.6) 14(6.7)
stimualted
influenza
8.5(1.5) 11.6(3.1) 124(24) 127(32) 74(12) 71(15) 14(7.9) 20(7.8)
virus-
stimulated
16.6(4.4) 21.0(7.3) 130(29) 144(34) 66(14) 70(13) 13(8.3) 19(7.4)
* Values are expressed in the format o f mean (s.d.).
III. 7 Examination on Monocyte-mediated NK Cell Activation in Response to Influenza 
Virus
• Comparison in frequency o f  monocytes between young and older subjects
Monocytes play an important role in cell-cell contact regulation of NK cell 
activation(229). We wanted to know whether the frequency o f monocytes in PBMC was 
different between young and older subjects. As indicated in Table III, there was no 
significant difference in the frequency o f CD 14+ monocytes between the two age groups, 
indicating the aging effect on monocyte-mediated NK cell activation, if  any, was not a 
result from age-related numerical deduction o f monocyte.
• Examination o f  monocyte-mediated N K  cell activation in young and older adults
Monocytes regulate NK cell activation via secreting cytokines and cell-cell contact 
mechanism in response to influenza virus; therefore this interaction can be a potential 
contributor for NK cell activation down-regulation in older people. It is o f interest to 
know how monoyctes isolated from young or older people differentially mediate NK cell 
activation in response to influenza virus. We performed FI assays, in which equal 
amounts o f CD 14+ monocytes generated by pooling equal amount o f monocytes isolated 
from individual donors in young or older subjects were added to moncyte-depleted,
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Figure 18. Comparison of influenza HA and CD69 expression on monocytes between young and 
older subjects
Media (mock)- or influenza-activated PBMC from 12 healthy young and 24 healthy older subjects 
were measured by live cell staining and flow cytometry for HA and CD69 expression on Cdl4+ 
monocytes. Regular FI culture set-up procedures were followed except for not having BFA added into 
the culture. One ju.1 of influenza virus was used for infection. The cells were cultured for 14-16 hours 
before staining was initiated. A, intensity of HA (left) or CD69 (right). B, fold of increase in HA and 
CD69 intensity upon influenza stimulation. Horizontal bars represent the median.
namely Mono(-) PBMC and infected by influenza virus. We could not detect a 
significant difference in NK cell activation in Mono(-) PBMC from either young or old 
subjects between addition o f non-aged (young) monocytes and aged (older) monocytes 
(Figure 19), although there was a trend of lower NK cell activation in older subjects
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between addition o f two kinds o f monocytes (p=0.08, Figure 19). The percent o f NK 
cells that were activated in the presence o f young and aged monocytes in the young 
subjects ranged from 0.8-18.2% with median=10.1% and 0.6-24.3% with median=4.2%, 
respectively. Percent o f NK cells that were activated in the presence o f young or aged 
monocytes in the older subjects ranged from 0.5-11.7% with median=2.6% and 0.2-6.7% 
with median=l .2%. We didn’t observed an up-regulation of NK cell activation when 
additional monocytes, whether young or aged were added to Mono(-) PBMC as 
compared to that without additional monocytes. There was a trend, though not having 
reached the significant level that NK cell activation was lower in older subjects than that 
in the young when Mono(-) PBMC from young and older subjects were treated the same 
way (Figure 19). There seemed to be an influenza-unrelated activation due to monocyte 
isolation procedure in influenza virus-stimulated Mono(-) PBMC for NK cell activation 
was significantly elevated in Mono(-) PBMC, regardless the age groups, compared to that 
in the untouched PBMC (Figure 17). From these data, we could not draw a conclusion 
on how monocytes from young and older subjects differentially mediated NK cell 
activation while it seemed the difference between young and aged monocyte in activating 
NK cells with lower activation by aged monocytes was more obvious in older Mono(-), 
PBMC than that in young Mono(-) PBMC. Whether this is a valid conclusion remains to 
be further investigated.
III. 8 Summary o f Results
• Specific Aim 1
1. NK cell activation measured as the frequency o f CD69+IFN-y+ NK cells as well as the 
intensity o f IFN-y in CD69+IFN-y+ NK cells in response to influenza viral stimulation in 
PBMC is reduced in older subjects as compared to the young subjects.
2. Down-regulated NK cell activation correlated with down-regulated IFN-o: level and T 
cell activation in response to influenza viral stimulation in PBMC in older subjects as 
compared to the young subjects.















































Figure 19. Effect of monocytes from young or older subjects on NK cell activation in response 
to influenza virus
Monocytes were isolated by using CD 14 magnetic beads from individual PBMC and pooled for 
either young (2-3 donors per pool) or aged (2-3 donors per pool) monocytes for study. One a 
hundredth million isolated pDC were co-cultured with 1 million individual PBMC in the 
presence of 1 fil of influenza virus in 96-well plate. Fastlmmune assay and flow cytometry was 
used to determine the frequency of activated NK cells. The graph represents data from 4 
independent experiments involving 9 young and 8 older subjects. Elongated bars represent 
the median.
3. Both IFN-a! and IFN-y play positive roles in stimulating NK cells to produce IFN-y in 
response to influenza virus as demonstrated by effects o f neutralizing antibodies against 
IFN-c^IFN-a/jS receptor or effects o f rlFN-Y
4. Plasmacytoid DC and T cells play a positive role in stimulating NK IFN-y production 
as demonstrated by pDC-depletion assays.
5. Lower frequencies o f pDC and CD3+ T cells in PBMC were observed in older subjects. 
Lower levels o f IFN-a secreted by purified pDC and lower frequency o f IFN-Y-producing
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CD3+ T cells in PBMC in response to influenza vims were detected in older subjects 
than young subjects.
6 . Plasmacytoid DC isolated from young subjects better facilitated NK cell activation 
than pDC isolated from older subjects in response to influenza viral stimulation in 
PBMC.
• Specific Aim 2
1. Supernatants generated from influenza vims-activated PBMC in the absence o f cell­
cell contact stimulated NK cells to produce IFN-y. Preventing NK cell contact with other 
cells by transwell significantly down-regulates NK cell to produce IFN-y
2. Expression of NK cell activating receptors NKp44 and NKp46 on NK cells in PBMC 
were elevated in response to influenza stimulation in both young and older subjects. 
Surprisingly, expression levels o f both receptors were higher in older subjects than that in 
the young whether PBMC were at resting, mock-stimulated or influenza-stimulated status.
3. No significant difference in expression levels o f influenza HA on monocytes upon 
influenza infection was observed between young and older subjects.
4. No significant difference in frequency o f monocytes in PBMC was observed between 
young and older subjects. Monocytes isolated from young subjects tended to better 
facilitate NK cell activation than monocytes isolated from older subjects in response to 
influenza vims in older subjects.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
62
IV. DISCUSSION AND CONCLUSIONS
IV. 1 Down-regulated Natural Killer (NK) Cell Activation in Response to Influenza Virus 
in Older Subjects
Influenza is a disease associated with high mortality and morbidity in elderly population 
(2-4). Natural killer (NK) cells play a critical role in controlling viral load at early stages 
o f immune defense by eliciting cytotoxicity and secreting cytokines, particularly IFN- y 
(82). NK cells respond to influenza infection and vaccination (85, 155, 156). Our study 
demonstrates a significant aging-related down-regulation of IFN-7  production by NK 
cells in response to influenza virus (Figure 5).
The aging-related impairment in NK cell EFN-7  production is manifested by a lower 
frequency o f CD69+IFN-y+- NK cells (Figure 3B) in influenza virus-infected PBMC from 
the elderly subjects than that from the young subjects. The frequencies o f CD69+IFN-y+ 
NK cells were calculated in both total NK cells and total lymphocytes. The frequencies 
calculated using these two different denominators were highly correlated with the 
correlation coefficients o f 0.90, 0.74 and 0.85 in the young, elderly and combined groups, 
respectively. We deem the necessity o f calculating CD69+IFN-yf NK frequencies in 
both total NK cells and total lymphocytes lies in two aspects. First, NK cells are 
phenotypically and functionally heterogeneous with CD56dimCD16bnght subset primarily 
executing cytotoxicity and secreting small amount o f IFN-7 , and CD56bnghtCD16dim 
subset being the primary IFN-y-secreting cells (82, 84). Using total NK cell number as 
the denominator can not guarantee the age-related decline in the frequency of 
CD69+IFN-7+ NK cells is due to the decline o f the IFN-y-producing NK cell number but 
not the increase o f the non-IFN-y-producing NK cell number. In fact, an age-related 
increase in peripheral NK cell number has been found in both CD56dimCD16bngbt and 
CD56bnghtCD16dlmNK subsets with higher increased number o f CD16bnght cells than 
CD56bnght cells (8 6 , 230, 231). Unfortunately, we were not able to differentiate these two 
subsets in our experiment due to the same fluorescent shared by CD 16 and CD56 
antibodies. Second, ignoring NK subsets, the age-related increase in the number o f total
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NK cells bears the potential to balance the age-related decrease in the frequency of IFN-y 
+ NK cells calculated in total NK cells. Calculating the frequencies o f IFN-y -producing 
NK cells in total lymphocytes becomes necessary in determining whether lower 
proportion o f IFN-y+- NK cells in total NK cells can be a fair reflection o f less IFN-y - 
producing NK cells in peripheral blood in elderly subjects than young subjects. As 
shown in Figure 5B, whether total NK cell number or total lymphocyte number was used 
as the denominator, the frequency o f CD69+IFN-y+ NK cells in response to influenza 
stimulation is lower in the elderly subjects than that in the young subjects, suggesting the 
lower frequency o f CD69+IFN-y+ NK cells results from the reduction in the number o f 
NK subsets that are capable o f producing IFN-y.
In addition to numerical decline, the aging-related impairment o f NK cell IFN- y 
production in response to influenza virus was reflected by the significantly lower IFN- y 
intensity in NK cells in the elderly subjects than that in the young subjects (Figure 5C). 
The lower IFN-y intensity indicates NK cells, as a heterogeneous entity in PBMC, are 
functionally impaired in IFN-y production in response to influenza virus in the elderly 
subjects compared to the young. It should be noted that this lower IFN-y intensity can be 
a consequence o f the reduced IFN-y production in NK cells in a per-cell basis and/or the 
relative increase in the proportion of CD16hlgh over CD56hlgh cells in the total IFN-y+
NK cells with no change in the per-cell based IFN-y production in a single NK cell.
Thus, no conclusion regarding truly functional impairment in per-cell based IFN-y 
production in NK cells in the elderly subjects compared to the young can be drawn 
without differentiating CD56hlgh versus CD16h,gh NK cell subsets, though NK cell as a 
whole does display aging-related functional defect in IFN-y production. The aging- 
related down-regulation o f IFN-y production by NK cells in response to influenza virus is 
not related to the impairment in signal transduction during the early stage o f NK 
activation for no significant difference in the frequency or intensity o f CD69+ NK cells 
has been detected between young and elderly subjects. This suggests early signal 
transduction during NK cell activation in PBMC in response to influenza infection is 
likely well preserved with advanced aging.
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In summary, our data demonstrates the significantly down-regulated human NK cell IFN- 
y production in PBMC from elderly subjects compared to young subjects in response to 
influenza infection. This aging-related down-regulation o f IFN-y production in NK cells 
is manifested by the reduction in the frequencies o f CD69+IFN-y + NK cells in total NK 
cells as well as in total lymphocytes, and in the amount o f IFN-y produced by total NK 
cells, but not in the early signal transduction reflected by CD69 expression. NK cell 
activation involves three activities: proliferation, cytotoxicity, cytokine, particularly IFN- 
y production (230). Evidence has shown that purified NK cells from the elderly subjects 
proliferate to the less extent responsive to IL-2 than NK cells from the young subjects 
while the IL-2 levels in response to influenza virus have been shown to be lowered with 
advanced aging under many, if  not all experimental conditions (171, 172, 175, 230). NK 
cytotoxicity is also known to be affected by aging. Thus, age-related changes have been 
detected in all three facets o f NK activation in response to influenza virus, suggesting NK 
cells could be one o f the major targets o f the aging process that contributes to the age- 
related impairment in immune defense against influenza.
IV.2 IFN-o, pDC and Down-regulated NK Cell IFN-y Production in Response to 
Influenza Virus in Older Subjects
IFN -ais a family of cytokines comprising 13 different functional subtypes (232, 233). 
IFN- a  have been recognized as a pro-Thl cytokine that stimulates NK and T cell 
cytotoxicity and IFN-y production synergistically with IL-18 (216, 234). In addition, 
type I interferons including IFN-a and IFN-/3, have been considered important in 
enhancing humoral immunity, particularly by providing the help for plasma cell 
differentiation (199, 235, 236). NK cell IFN-y production in response to influenza virus 
has been shown down-regulated in the elderly subjects compared to the young subjects in 
earlier session of our study (Figure 5). How important IFN-a is involved in influenza- 
induced NK cell IFN-y production in the aging context has not been addressed previously. 
Our data have suggested IFN-q: is a significant contributor participating in the aging- 
related down-regulation o f NK cell IFN-y production in response to influenza virus by 
providing the following evidences.
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First, in the presence o f IFN-a or IFN-a//3 receptor neutralizing antibodies, the frequency 
of IFN-7  producing NK cells considerably decreased compared to the control, indicating 
IFN-a is a significant mediator for NK cell IFN-7  production in influenza virus- 
stimulated PBMC (Figure 7). The importance o f IFN-a in this scenario is further verified 
by the use o f CpG ODN2216, and the depletion of pDC, one o f the major sources o f IFN- 
a  in PBMC (237). The CpG is known to specifically induce IFN-a production in pDC 
though activating TLR-9 (238). Our data has verified that CpG ODN2216 specifically 
induces IFN-a production in CD123high (pDC) cells but not CD1231ow (monocytes) 
cells (Figure 8 A). The frequency of IFN-7 -producing NK cells in influenza-stimulated 
PBMC increases in parallel with the elevated IFN-a production in the presence o f the 
CpG ODN2116 while decreases by pDC depletion (Figure 8B and 11 A), confirming the 
regulatory role o f IFN-a in stimulating NK IFN-7  production in response to influenza 
virus. We have realized that the inhibitory effect o f pDC depletion on NK IFN-7  
production is not as strong as the neutralization o f IFN-a or its receptors, and replacing 
the depleted pDC back to the culture only created a trend but not the significant level of 
restoration o f the frequency o f IFN-7 -producing NK cells (Figure 7 and 8 A). This is 
likely due to the effect o f IFN-a produced by the remaining monocytes and possibly pDC 
in PBMC after pDC depletion. We have also tried to examine the effect o f rIFN-a on NK 
IFN -7  production in a dose dependent manner but have not detected any effect. This is 
unlikely due to the mismatched IFN-a subtype used in our experiment because IFN-02, 
the subtype we used is known to be a functioning subtype in PBMC in response to 
influenza virus and was detected by IFN-a2 specific antibody in our assays (ref, Figure 
8A). Possible reasons could be that endogenous IFN-a level had been saturated before 
rEFN-a was added and/or there needs another soluble factor working in conjunction with 
IFN-a2 to optimize the effect.
Second, we have found IFN-a level in the supernatant o f activated PBMC is significantly 
reduced in the elderly subjects compared to the young subjects in response to influenza 
viral stimulation, which coincides with the lower frequency o f IFN-7 -producing NK cells 
described earlier (Figure 6A and 5). The correlation between IFN-a level and the
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frequency of IFN-7 -producing NK cells from these samples is moderate (r=0.56) but 
statistically significant (p<0.05, Table II). Moreover, we have found about 30% 
reduction in the average frequency o f pDC in PBMC and 38+13.4% (mean+SD) 
reduction in the amount o f IFN-a produced by purified pDC stimulated with influenza 
virus in the elderly subjects compared to the young subjects, suggesting that both 
numerical and functional impairments are present in pDC in response to influenza 
infection in the elderly. Figure 14 further suggests the existence o f intrinsic defects in 
pDC in older subjects by showing higher frequency of IFN-y+ NK cells in the presence 
o f pDC isolated from the young subjects than those isolated from the older subjects in 
response to the influenza virus infection. That pDC secrete higher amount o f IFN-a than 
monocyte in a per-cell basis while IFN-a+ cell number are comparable between CD123hi 
(manifest o f pDC) and CD1231ow (majority monocytes) cells (data not shown) suggests 
that pDC is more productive in IFN-a generation than monocytes in response to influenza 
infection. Considering the significant role o f IFN-a in activating NK cells, it is not 
surprising that the aging-associated impairments in pDC will significantly contribute to 
the down-regulation o f NK IFN-7  production in response to influenza virus in the elderly 
subjects.
IV.3 IFN-y, T cells and Down-regulated NK Cell Activation in Response to Influenza 
Virus in Older Subjects
In addition to its role as an effector cytokine, IFN-y plays a regulatory role in mediating 
Thl immune response, promoting NK cell differentiation and influencing antibody 
production (176, 184). IFN-y is secreted by CD4+ type I helper T cells, CD8+ cytotoxic 
T cells and NK cells in response to influenza infection (174, 239). Our preliminary 
kinetic study on CD69 expression in PBMC suggests that T cell activation precedes NK 
cell activation in response to influenza virus, generating the possibility that IFN-y 
produced by T cells influences NK cell IFN-y production in response to influenza virus 
(S. Figure 3).
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The role o f IFN-y in regulating NK IFN-7  production specifically in response to influenza 
virus is verified in our study. First, our data indicates a trend that the frequency o f IFN-y 
-producing NK cells declines in the presence of neutralizing antibodies against IFN-y, 
though the decline does not reach significant level (Figure 9). In fact, the trend o f the 
decline is obvious in the subjects with higher baseline levels o f IFN-y+ NK cell 
frequency than those with relatively lower baseline levels (Figure 9), indicating the 
responsiveness to the neutralizing antibody may require certain baseline limit. Second 
and more importantly, in response to influenza virus purified (CD56+ and/or CD 16+) NK 
cells can not be activated to produce IFN-y in the presence of monocytes unless rIFN-y is 
added, indicating the importance o f pre-existing IFN-y in inducing NK cell IFN-y 
production (Figure 10). Moreover, purified NK cells can not be activated to produce 
IFN-y in the presence o f combination o f influenza virus and rIFN-y (data not shown), 
indicating IFN-y mediates NK cell activation via acting on monocytes. He and 
Romagnani have reported previously that the production of IFN-y in CD56bright NK 
cells is mediated by CD3+ or CD4+ T cells in an IL-2-dependent manner (159, 222). 
Monocytes are not known to be a source o f IL-2 but IL-15, a cytokine that share 
similarity with IL-2 and capable to activate NK cells via a NK-monocyte contact- 
dependent mechanism (240, 241). It will be o f interest to see whether IFN-y is able to 
induce IL-15 secretion in monocytes and further mediate NK IFN-y production in 
response to influenza virus. Last, we have tried to deplete CD3+ T cells from PBMC but 
have not found the difference in NK cell IFN-y production between CD3+ T cell-depleted 
and non-depleted PBMC. Interestingly, when isolated T cells were added back to the 
CD3(-) PBMC, there exhibits a T cell amount-dependent increase in NK IFN-y 
production in response to influenza stimulation (Figure 11B), supporting the role o f T 
cells in positively influencing NK IFN-y production. We think the unresponsiveness o f 
NK IFN-y production to CD3+ T cell depletion might be due to the non-specific 
activation in T(-) PBMC caused by the isolation procedure.
Taken together, our data suggest a positive role o f existing IFN-y on NK cell EFN-y 
production prior to NK activation. The source o f the earlier generated IFN-y is likely the 
activated memory T cells. Importantly, down-regulation of IFN-y production in CD4+
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Thl and CD8+ cytotoxic T cells in response to influenza infection and vaccination with 
advanced aging has been documented (81, 174, 188, 242). Consistent with the literature, 
our data shows that IFN-y production determined as the frequency o f IFN-y + CD3+ T 
cells in PBMC stimulated with influenza virus is reduced and correlates with the 
decreased frequency o f IFN-y-producing NK cells in the elderly subjects compared to the 
young subjects (Figure 5B, 6B and II). Along with the decreased IFN-yf T cell 
frequency, a lower frequency of total peripheral T cells is found in the elderly subjects 
than in the young subjects (Table III), indicating both numerical and functional 
impairment o f IFN-y producing T cells is associated with aging in response to influenza 
virus. Considering the significant role o f IFN-y in mediating NK cell IFN-y production, 
we believe the age-associated down-regulation of T cell IFN-y production contribute to 
down-regulated NK cell IFN-y production in older people in response to influenza virus.
IV.4 Cell-cell Contact Regulation in NK Cell Activation in Response to Influenza Virus 
in an Aging Context
Cell-cell contact between NK cells and antigen presenting cells, particularly dendritic 
cells and monocytes has been suggested a required condition for different aspects o f NK 
cell activation (229). For instance, in human ex vivo experiments, preventing the contact 
between monocytes or monocyte-derived mDC can reduce NK cell IFN-y secretion, 
cytotoxicity and CD69 expression and preventing the contact between pDC and NK cells 
can lower CD69 expression on NK cells without affecting NK IFN-y secretion and 
cytotoxicity in response to influenza virus (194, 239). Consistent with these findings, our 
data shows a significant reduction in both the frequency of IFN-y+ NK cells and the 
CD69 intensity in NK cells in response to influenza virus when cell-cell contact between 
NK cells and NK(-) PBMC is prevented compared to when the contact remains available 
(Figure 16). On the other hand, our data shows purified CD56high NK cells can be 
activated by supernatant generated from influenza-stimulated PBMC without the 
presence o f contacting with other cell types, suggesting cellular contact between NK cells 
and antigen presenting cells (APC) may not be an essential condition, but possibly 
required for the optimal level o f NK cell activation (Figure 15 and 16).
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The mechanism of cellular contact between NK cells and APC to mediate NK activation 
could lie in the reciprocal interactions between NK cells and APC, that is, cellular contact 
is required for full activation o f APC and conversely fully activated APC secrete optimal 
levels o f cytokines to promote NK activation (194). NK receptors or other molecular 
elements that participate in this cell-cell contact regulation are not clear yet. But 
evidence has shown that NK natural cytotoxic receptors (NCR) NKp44 and NKp46 
specifically recognize influenza HA and sendai virus hemaglutinin-neuraminidase (HN), 
both viruses inducing cytokine as well as NK- monocyte-derived macrophages contact- 
dependent NK cell activations (229). NKp44 and NKp46 are known to be exclusively 
expressed on NK cells and mediate NK cytotoxicity (202, 217). Our data shows that 
influenza virus enhances the expressions o f these two receptors on NK cells (Figure 17A 
and B). Without knowing the role o f these receptors in mediating NK cell IFN-7  
secretion, we started with examining how aging influences the expressions o f the 
receptors by comparing their expression levels on NK cells before and after influenza 
stimulation between the young and the older subjects. Our data shows whether at resting, 
mock- or influenza-stimulated status, NKp44 intensity is higher in the older subjects than 
that in the young (Figure 17A). NKp46 intensity level is comparable between the young 
and the old subjects independent o f the treatments while the frequency o f NKp46+ NK 
cells in lymphocytes is significantly higher in the older subjects than that in the young, 
leading to a numerical increase in NKp46+ NK cells with advanced aging (Figure 17A 
and B). The higher frequency or expression level o f NKp44 and NKp46 on NK cells 
from the elderly subjects than the young subjects can hardly explain the aging-related 
impairment in NK cell IFN-y production in response to the influenza virus. But there are 
a few possibilities that might help understand this contradiction. First, a frequency 
change does not always positively correlates with a functional change. We did not 
perform functional analysis on the NCR receptors, therefore that the receptor-positive NK 
cell frequency increases as a compensatory mechanism in response to the declined 
function o f the receptors remains possible. Second, the time when the measurements (12- 
14 hours post viral stimulation) were done may not be the optimal time point to detect the 
difference in the receptor expression between the two age groups. It is reported that
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influenza vims infects and the viral replication continues for 4-6 hours before being 
halted in human peripheral monocytes (243). It is possible that the lower receptor 
intensity in the NK cells from the young subjects than those from the older subjects at the 
time of the detection results from the kinetic difference in the receptor expression 
between the young and the elderly subjects, or more specifically is caused by the earlier 
declining o f the elevated receptor expression on the surface o f NK cells in response to 
influenza vims in the young subjects than in the older subjects. Future studies addressing 
these possibilities may help clarify the observation.
To examine whether monocytes from young or older people function differentially in 
stimulating NK cell to produce IFN-y in response to influenza, we have examined NK 
cells in monocyte-depleted PBMC with restoration o f monocytes isolated from either the 
young or the elderly subjects. Unfortunately, we could not detect the significant 
differences in NK cell IFN-y production between young and old monocyte-mediated 
conditions in either the young or the elderly group (Figure 19). In spite o f this, there was 
a trend that the young monocytes facilitate a better NK cell activation than the aged 
monocytes, particularly for the older subjects (Figure 19). Increasing sample size in 
future studies might help generate more significant data and better delineate the role of 
monocytes in regulating NK cell activation in an aging context.
It is interesting that in the transwell experiment when CD56+ NK cell was in transwell 
and CD56(-) PBMC were in the regular well, not only the IFN-y production o f NK cells 
in the transwell was down-regulated but also that o f the T cells in the regular well (data 
not shown). This is consistent with our previous observation that NK cell activation 
highly correlates with T cell activation in PBMC in response to influenza stimulation 
(Figure 4 and Table II). A simple explanation would be that preventing cell-cell contact 
down regulate NK cell IFN-y production, which in turn affect monocyte activation and 
consequently lead to down-regulated T cell activation. If  this was true, a reciprocal 
regulation between NK cell and T cell activations by IFN-y autocrine/paracrine 
asecretions could be established through the link o f monocytes.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
71
In summary, cell-cell contact regulation between NK cells and APC, particularly 
moncytes, monocyte-derived mDC and macrophages have been suggested as an 
important part o f the requirements for optimal NK cell activation. Our data has 
confirmed that both cell-cell contact between NK cells and APC and soluble factors play 
a significant role in inducing NK cell IFN-7  production. How cell-cell contact functions 
alone and cooperates with soluble factors to activate NK cells remains to be elusive.
IV. 5 Potential Roles o f Other Soluble Factors in Aging-related Down-regulation o f NK 
Cell IFN-y Production in Elderly Subjects in Response to Influenza Virus
Our study has suggested that aging-related reduction in pDC IFN-o; and T cell IFN-y 
productions contribute to the impairment in NK cell IFN-y production in PBMC in 
response to influenza virus for the elderly adults. The fact that no significant NK cell 
IFN-y production was detected when isolated CD56+NK cells were stimulated with IFN- 
a  alone, IFN-y alone, influenza alone or any combination of the three stimuli (data not 
shown) indicates other factors are required for inducing the NK cell activity in response 
to influenza. Correlation analysis in the combined young and elderly subjects reveals 
moderate correlations between the supernatant IFN-a level and the frequency o f IFN-y - 
producing NK cells (r=0.56), and weak correlation between the IFN-a level and the 
frequency of IFN-y-producing T cells (r=0.35), further supporting that multiple factors 
are involved in NK and T cell activation in PBMC and weaken the linear relationship 
between the supernatant IFN-a level and the frequencies of IFN-yF NK or T cells (Table 
II).
Besides IFN-a and IFN-y, other soluble factors that potentially display the age-related 
changes and able to influence NK IFN-y production in an aging context include, but are 
not restricted to IFN-/3, IL-18, TNF-a and IL-2 (74, 234). IFN-/3 is one of the major type 
I IFNs that shares the similarities with IFN-a in antiviral effect and inducing NK cells 
and T cells to produce IFN-y (232). IL-18 is known to be able to induce NK and T cell 
cytotoxicity and IFN-y production synergistically with IFN-a//3, IL-12 and/or TNF-a, 
among which, IL-12 is not known to be significantly produced in human PBMC in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
72
response to influenza vims (48,157,193, 244,245). Our previous data has shown 
PBMC from elderly subjects secrete lower level o f TNF-a in supernatant than young 
subjects at 3 hours but not 18 hours post influenza A stimulation, indicating a potential 
role o f TNF-a at early stage o f immune reactions in contributing to the age-related NK 
activation down-regulation (174). Surprisingly, in the same study no significant 
difference in IL-2 level between young and old subjects were detected, indicating IL-2 
level may not be necessarily an essential factor for the age-related impairment o f NK 
IFN-y production in our experimental system, although IL-2 levels have been shown to 
be down-regulated with advanced aging in response to influenza stimulation under many 
other conditions (118,119, 172, 175, 225, 246). Information about the age-related 
changes in the productions o f IFN-b and IL-18 are very limited up to date, therefore their 
contribution to NK activation including IFN-y production in the aging context remains 
unclear.
In addition to external factors, internal defects o f NK cells with aging should be taken 
into consideration when comparisons in NK activation are made between different age 
groups. Literatures have shown that purified peripheral NK cells from elderly subjects 
display lower CD69 expression and proliferation ability in response to IL-2 than those 
from young subjects, indicating intrinsic impairment in NK cells do exist with advanced 
aging (230). On the other hand, studies on the expressions o f cytokine receptors on NK 
cells have not suggested a difference in IL-2 receptor expression whether on resting or 
IL-2-stimulated NK cells between young and elderly subjects(247). Moreover, Plett and 
others even reports that higher level o f IFN-oZ/3 receptors with comparable IFN- 
oh/receptor binding activity is found on NK cells from aged mice than young mice. But 
this elevated IFN-aZ/S receptor expression in the aged mice may be associated with 
enhanced apoptosis o f NK cells induced by IFN-a. Apparently more studies are needed 
for obtaining a clear picture o f how NK cell functions are influenced by aging. Future 
investigations on both the intrinsic and extrinsic factors related to NK activation will 
provide more valuable insights into the aging-related changes on NK cell activation in 
responses to influenza virus.
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IV. 6 Conclusions
In this study we have compared IFN- 7  production in NK cells in influenza virus- 
stimulated PBMC between young and elderly subjects and investigated soluble factors, 
particularly IFN-a and IFN-y, and cell-cell contact between NK cells and other cells in 
PBMC in mediating the NK cell IFN-y production in 311 aging context. Based on our data, 
we conclude:
1. Interferon-alpha (IFN-a) and IFN-y are important regulatory cytokines in stimulating 
NK cells to produce IFN-y in PBMC in response to influenza virus. Aging-related 
numerical and functional impairments in pDC and T cells lead to the reduced production 
o f IFN-a and IFN-y, which contribute to the down-regulated NK cell IFN-y production in 
the elderly subjects compared to the young subjects.
2. Cell-cell contact regulation between NK cells and APC in PBMC may be important in 
activating NK cells to the full extent in conjunction with soluble factors in response to 
influenza virus. How cell-cell contact regulates NK cell activation and what age-related 
differences in components involved in the cell-cell contact regulation contribute to the 
impaired NK cell activation in older people remain to be elucidated.
IV.7 Significance o f the Study
Immune senescence leads to increased mortality and morbidity and decreased vaccine 
efficacy associated with influenza with advanced aging. As a critical component o f the 
innate immune system, NK cells play an important role in defending viral infection by 
eliciting cytotoxicity and secreting IFN-7 . Our study has focused on delineating the 
aging-related changes in NK cell IFN-y production in response to influenza virus and 
revealing potential causal factors for these changes. We have concluded that IFN-a and 
IFN-y are important mediators for influenza-induced NK cell IFN-y production, and 
aging-related impairments in IFN-a production by pDC and IFN-y production by T cells 
contribute to the down-regulated NK cell IFN-y production in the elderly subjects
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compared to the young subjects. We have also suggested that the cell-cell contact 
between NK cells and monocytes is important in activating NK cells to produce IFN-y to 
the full extent. To our knowledge, this is the first systemic investigation about the aging 
effect on NK cell IFN-y production in response to influenza virus. Our data supports that 
NK activity can be one o f the major targets o f the aging process that leads to the immune 
dysfunction in the elderly people in response to influenza virus.
The significance of NK cells in influenza-induced immune response extends from the 
innate immunity to the adaptive immunity via the production o f IFN-y, the manifest 
cytokine o f Thl lymphocytes by NK cells. Previous studies have suggested Thl but not 
Th2 lymphocytes prevent lethal dose o f influenza virus or promote the recovery in 
normal or aging-accelerated mice, and Thl but not antibody response correlates with the 
outcome of influenza vaccination in human (174, 189, 248,249). These evidences 
suggest that Thl immunity is an important part o f anti-influenza immune responses. Our 
earlier work has shown an age-related impairment in IFN-y production in influenza- 
specific CD4+ Thl cells and cytotoxic T cells in older adults. Since T cells and NK cells 
are the predominant source o f IFN-y, our current study completes the picture that the 
deficiency o f IFN-y production in elderly adults in response to influenza virus is 
attributed not only to the T cells but also to the NK cells. Moreover, our study has 
confirmed the importance o f IFN-a and IFN-y in mediating NK IFN-y production 
specifically to influenza virus and pointed out that the aging-related impairments in the 
productions o f these interferons by pDC and CD3+ T cells contribute to the aging-related 
down-regulations in NK cell IFN-y production. Therefore, our study has provided 
valuable information on how Thl immune response is impaired in the elderly people in 
response to influenza virus.
NK cell activities, particularly cytotoxicity have been documented to be responsive to 
influenza vaccination with live-attenuated, inactivated trivalent split vaccines or 
inactivated viral particles in human, indicating NK cells are significantly involved in 
vaccination-induced defending mechanism against influenza (155, 156, 223). However, 
information about NK cell IFN-y production in response to influenza vaccine is very
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limited if  not completely missing. We deem monitoring NK cell IFN-7  production 
should be as equivalently important as monitoring NK cytotoxcicity for a vaccination 
study. Although not directly related to a vaccine study our finding is valuable to be used 
as a reference at the starting point for a comparative influenza vaccine study between 
young and elderly subjects.
Our study utilizes human blood as the experimental material, therefore bypasses the 
possible discrepancies in information translation o f the findings from animals to human. 
It’s our strong belief that our findings will bring valuable insights on how aging 
influences innate immune system and Thl immunity and help establish the fundamentals 
for developing more effective prophylactic and therapeutic approaches for elderly people.
IV. 8 Restrictions o f the Study
Similar to many other studies, our study is restricted in certain ways. First, influenza is a 
localized but not systemic infection (1). Using influenza-stimulated PBMC is a mimic of 
a systemic infection. However, this restriction is hard to be avoided due to the limited 
tissue types to be obtained from human subjects. Second, we did not consider the 
survival factors for the elderly subjects in our study. Aging is commonly associated with 
a survival issue. If the selection pressure for the survival is unrelated to the variable to be 
investigated, survival factor will not be important. Otherwise, it will be affecting the 
validity o f the age-related change because the “change” could be a simply “unchanged” 
fact that is survived from other age-related mortality. Unfortunately, in most occasions it 
is hardly to know whether the selection pressure for the survival is related to the variable 
to be investigated or not. Longitudinal study, which is more cost-inefficient, would be a 
solution to avoid the influence o f the survival factor. Third, it is common in human 
studies that sample availability restricts sample size, duplication possibility, repeating 
possibility. These restrictions may increase the chance o f getting data with bigger 
variations and un-conclusive results.
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IV.9 Future Directions
We would like to continue to investigate soluble factors in influenza-induced Thl 
immunity in an aging context. We would differentiate subgroups o f NK cells, 
particularly differing CD56high versus CD561ow cells so that the aging-related absolute 
and relative increase o f the frequencies o f IFN-7-producing NK subsets and decrease in 
the per-cell-based IFN-y intensity will be clarified. Further more, questions as what is the 
mechanism by which cell-cell contact regulates NK cell activation; how relatively 
important pDC versus monocytes are in producing IFN-a; which subtypes o f IFN-a are 
important; whether IFN-b participates in aging-related changes in immune regulation; 
how IFN-a contributes to the impaired T cell activation in the elderly; how IFN-y 
influences monocytes and consequently influences NK cell activation; and how NK cells 
influence T cell function in response to influenza virus would be of great interest to be 
investigated.
We would also like to investigate the relationship between Thl response and antibody 
response in influenza-induced immunity. Generating protective antibody is one o f the 
primary goals o f the vaccination. Knowing how cytokines influence antibody production 
in young and elderly subjects in response to influenza infection and vaccination will be o f 
great value for providing the fundamentals for developing more effective prophylactic 
and therapeutic approaches for human.
Lastly, we would like to evaluate the potential o f IL-12 family o f cytokines in enhancing 
influenza-induced human Thl immunity in the elderly subjects. Interleukin 12 (IL-12) 
and IL-23 are not produced in human PBMC stimulated with influenza while exogenous 
IL-12 significantly enhances IFN-y production in human PBMC either alone or 
synergistically with influenza virus (48, 49, and data not shown). Whether IL-12 family 
o f cytokines can be developed into an adjuvant for influenza vaccines in the elderly 
people is o f interest to be evaluated.
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S. Figure 1. Frequencies o f total NK cells in total lymphocytes in young and elderly 
subjects.
One million PBMC from each of 15 healthy young and 25 healthy older subjects were stained for 
CD56+orl6+CD3- NK cells and NK cell frequencies were determined by flow cytometry. 
Columns represent the mean and error bars represent the standard deviation.











S. Figure 2. Expression o f CD69 on NK cells in PBMC from young and elderly subjects.
One million PBMC from each of 15 healthy young and 25 healthy older subjects were stimulated 
with 1 jtil of influenza virus in 96-well plate overnight. Fastlmmune assay and flow cytometry 
was used to determine the expression of CD69 and IFN-y in NK cells. A, CD56+orl6+ NK cells 
were gated out of lymphocytes and analyzed for CD69 intensity on CD69+IFN-y+ or CD69+DFN- 
y- NK cells by flow cytometry. Columns represent the mean and error bars represent the standard 
deviation. B, comparison of CD69+IFN-y- NK cell frequency in total NK cells between young 
and older subjects. Columns represent the mean and error bars represent the standard deviation.
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S. Figure 3. Sequential activation o f monocytes, T cells and NK cells in PBMC in 
response to influenza infection
One million PBMC from each of 3 healthy young subjects were stimulated with 1 /d of influenza 
virus in 96-well plate overnight followed by staining with anti-human CD3(FITC), 
CD56/16(PE), CD69 (PerCP) and CD14 (APC) antibodies. Frequencies o f CD69- 
expressing cells in each cell type were determined by flow cytometry. The percent o f 
completion o f activation determined as the ratio o f frequency o f CD69+ cells at each time 
point over the frequency o f CD69+ cells at 21-hour time point are shown.
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